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The effectiveness of drug abuse treatment for clients coerced into care remains controversial.  
Some studies find clients with legal pressure do better than those without legal pressure, 
while others report the exact opposite.  Opposing views are often fueled by the wide-ranging 
models that guide delivery of addiction treatment.  The present study examined how 
participants with and without legal pressure to attend treatment responded to a motivational 
(MET) vs. traditional (TAU) form of addiction treatment.  Additionally, the predictive value 
of the Readiness to Change (RTC) score, from the URICA, was assessed across days of 
substance use and treatment retention.  Legal status was shown to have a significant effect on 
days of primary substance use per week and treatment retention, regardless of intervention 
condition.  The RTC score was shown not to be predictive of days of primary substance use 
or treatment retention. Research and clinical implications and future directions are discussed. 
 
ix 
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The effect of legal status on responses to brief motivational interviewing with substance 
users 
Substance Use Disorders 
 Substance abuse and dependence affects 22.2 million Americans each year (NSDUH, 
2008).  The treatment of addiction and addiction-related problems continues to be a heavily 
argued and discussed field.  The medical and social costs of a substance use addiction of any 
type are costly. In 2003 it was estimated that 21 billion dollars per year was spent on 
addiction services (NSDUH, 2008), with costs associated with drug and alcohol use (i.e. 
health care, lost wages, legal, etc.) accounting for a total of $500 billion annually (Jason & 
Ferrari, 2010). 
Prevalence and Diagnosis of Substance Use Disorders 
Substance Use Disorders are present in a surprisingly large proportion of the 
population and account for a significant amount of the costs associated with health care and 
mental health services each year.  Data from the National Epidemiological Survey on 
Alcohol and Related Conditions (NESARC) conducted by the National Institute on Alcohol 
Abuse and Alcoholism (NIAAA) in 2001-2002, indicated that Alcohol Use Disorders afflict 
17.6 million adult Americans.  These findings, derived from a national, face-to-face survey 
(N=43,093), noted that alcohol use disorders (AUD) were more common among men and 
younger respondents than among women and older respondents (Compton, Thomas, Stinson 
& Grant, 2007).  These results are consistent with an earlier study which suggested 17.4 
million adult Americans suffered from AUD’s (Sobell, Sobell, & Gavin, 1995), and present 
some of the most comprehensive data looking at substance use and abuse in the United 
States. 
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A more recent survey conducted by The Substance Abuse and Mental Health Services 
Administration (SAMHSA), is the 2008 National Survey on Drug Use and Health (NSDUH).  
Data for this study were collected between 2007-2008 (N=136,606) (SAMSHA, 2010).  A 
representative sample of 136,606 individuals aged 12 or over were interviewed in their place 
of residence.  According to the results of this survey 20.1 million (8%) Americans aged 12 or 
over had used illicit drugs in the past month (9.3% of youths aged 12-17, 19.6% of adults 
aged 18-25 and 5.9% of adults over 25), and 51.6 % (129.0 million) of persons aged 12 or 
over used alcohol in the past month.  A total of 23.3% (58.8 million) of people aged 12 or 
over had engaged in binge drinking (5 or more drinks in the same day) in the past month.  
Heavy drinking, defined as 5 or more days of binge drinking in a month, was engaged in by 
6.9% of the population, or 17.3 million Americans aged 12 or over.  In 18-25 year olds, the 
reported rates of binge drinking and heavy drinking were 41% and 14.5%, respectively.   
Substance use disorders (SUD), have a long history in the Diagnostic and Statistical 
Manual of Mental Disorders, first conceptualized as sociopathic personality disturbances in 
DSM-I and later personality disorders and sexual deviations in DSM-II (Nathan, Skinstad, 
Langenbucher,1999). With DSM, DSM-III, and DSM-III-R, SUDs were formalized and 
separated into two distinct diagnoses: Substance Abuse and Substance Dependence. 
Substance Abuse was viewed as the less severe of the two disorders.  Further refinements in 
the criteria occurred for Substance Abuse and Dependence in the DSM-IV.  According to the 
DSM-IV, Substance Dependence criteria are to be applied first, then, if an individual does 
not meet these criteria, a diagnosis of Substance Abuse considered. Text revisions were made 
to DSM-IV in 2000 to reflect new empirical evidence and correct factual errors (APA, 2000).  
Although there were refinements in the diagnostic criteria for SUDs between DSM-III-R and 
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DSM-IV, these changes were not substantive. Changes included: 1) the addition of qualifiers 
of “with or without physiological dependence” to the disorder of Substance Dependence; and 
2) moving the criterion of social and occupational consequences of substance use from 
Substance Dependence to Substance Abuse. Additional changes are planned for the DSM-V, 
due out in 2012.  It is uncertain if these changes will represent a major or minor change in 
SUD criteria.  Specific criteria for the current DSM-IV-TR Substance Dependence and 
Substance Abuse diagnoses are summarized below (DSM-IV-TR, 2000). 
A diagnosis of substance dependence requires demonstrating three or more of the 
following; 1) tolerance, 2) withdrawal, 3) compulsive use, 4) “persistent desire or 
unsuccessful efforts to cut down”, 5) increased time spent in substance seeking behaviors, 6) 
continued use despite negative physical or psychological problems, and 7) social, 
occupational or recreational activities given up because of substance use.  Tolerance is 
defined in the DSM-IV as “a need for markedly increased amounts of the substance” for 
achieving the same high or “a markedly diminished effect”.  Individuals diagnosed with 
dependence experience withdrawal symptoms or avoid them through the use of other 
substances.  Compulsive use is defined as taking the substance in larger amounts over a 
longer period of time than intended (DSM-IV-TR p. 181, 2000).   
Substance abuse is defined according to the DSM-IV-TR as a “pattern of substance 
use leading to clinically significant impairment or distress” in one or more of four criteria 
and never meeting the criteria for Substance Dependence.  Substance use has resulted in 1) 
“failure to fulfill major role obligations at work, school, or home”, 2) is the “recurrent use of 
the substance in situations in which it is physically hazardous”, 3) is “recurrent substance-
related legal problems”, 4) “continued substance use despite having persistent or recurrent 
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social or interpersonal problems caused or exacerbated by the effects of the substance” 
(DSM-IV-TR p. 182-183, 2000).  Meeting one or more of the above criteria is enough to 
meet criteria for a Substance Abuse diagnosis.  
It is estimated that 8.9% (22.2 million) of Americans met classification for substance 
abuse or dependence in the past year.  Of this population, 3.1 million were classified with 
dependence or abuse of both alcohol and illicit drugs, 3.9 million were dependent or abusing 
illicit drugs but not alcohol, and 15.2 million were dependent or abusing alcohol but not 
illicit drugs (NSDUH, 2008).  There is no indication of a change in prevalence between 2002 
and 2008 (22.0 million in 2002 and 22.2 million in 2008) (NSDUH, 2008).  In 2008, it is 
estimated that 23.1 million persons aged 12 and above were in need of treatment for illicit 
drug and/or alcohol use problems.  Of this 23.1 million, only 2.3 million received treatment, 
meaning that 20.8 million people in need of treatment had not received any specialty 
treatment at a substance abuse facility in the past year.  Of those that did not receive 
treatment 1.0 million (4.8%) felt that they needed treatment, with 23.3% (233,000) of this 
sub-group making an effort to get treatment, and 76.7% (766,000) making no effort to get 
treatment (NSDUH 2008). 
The substance abuse literature continues to support that substance use disorders are a 
chronic, relapsing condition.  Despite this, outside the substance abuse literature, these 
disorders consistently are conceptualized as a social problem, because of the effects on social 
systems (legal problems, lost work, etc.).   This view holds that substance dependence is 
primarily a social problem requiring prohibition and legal enforcement rather than a health 
problem that requires prevention and treatment.  It is likely that this “SUDs as a social 
problem” perspective is held and maintained because 40% to 60% of patients treated for 
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alcohol or other drug dependence return to active substance use within a year following 
treatment discharge (McLellan & McKay, 1998; Finney & Moos, 1992).  According to 
McLellan, Lewis, O’Brien, Kleber (2000), viewing drug and alcohol dependence as a 
curable, acute condition supports this social problem view.  However, if a chronic illness 
model is adopted for SUDs, the standards for treatment and outcome expectations would be 
found among other chronic illnesses such as type 2 diabetes mellitus, hypertension, and 
asthma (McLellan et al., 2000).  With these chronic conditions, as with substance abuse, 
there is a high relapse of symptoms when treatment is withdrawn. 
It is important to recognize that in the population of over 23 million Americans who 
were in need of treatment, only 10% received this treatment (NSDUH, 2008).  There are 
several possible reasons why this is the case, some include, the inability to access services, 
lack of resources to pay for services, belief that treatment services do not work and stigma 
associated with seeking out these services.  
  Conceptualization of substance abuse by professionals in the field has changed 
considerably in the last thirty years, however, the general population has been slow to catch 
up.  Many still hold views about substance abuse that are outdated, and in many cases have 
been shown to be erroneous.  One such perspective is that substance use is a weakness of 
character, that abuse problems are the fault of the individual for engaging in "immoral" drug-
seeking behavior. As a result, the traditional social mechanism for controlling immoral 
behavior results in the criminal sanctioning of this behavior, and the person committing the 
behavior (Fingarette, 1989).  Another such view, popularized by twelve step programs, 
asserts that before a person can make a change in their behaviors they must hit their lowest 
point (i.e., “rock bottom”).  It is this lowest point that provides the motivation for all future 
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actions to avoid substances (Fingarette, 1989).  Another more nuanced stance, is that 
substance abuse is static and unchanging, and that attitudes toward substance use are also 
static and unchanging.  This view, and the others briefly described run contrary to the most 
recent and empirically supported models of substance use.  The Transtheoretical stages of 
change model and Self determination theory are both examples of such, and will be discussed 
more fully as a way of understanding substance use and the effectiveness of a motivational 
approach to treatment of substance use. 
Transtheoretical Model of Change 
 A diagnosis of substance abuse or dependence is an important way to categorize 
substance users, and it has been discussed in great detail, however it provides little 
information for the way in which we conceptualize the process of change from substance 
user to recovery.  The most prevalent and widely held way of conceptualizing this process of 
change is through the use of the transtheoretical model of change (Prochaska & DiClemente, 
1983). This model includes three dimensions representing critical elements of the change 
process: stages, processes, and levels of change (Prochaska, DiClemente & Norcross, 1992).  
Stages are a representation of the temporal and motivational aspects of change.  This process 
is the mechanism that facilitates the movement through the stages.  The five levels of change 
are, precontemplation, contemplation, preparation, action, and maintenance.  Though not 
initially included as a stage of change, relapse is now conceptualized as a unique part of the 
stages of change.  The stages of change can be thought of as a series of steps through which 
substance abusers traverse.  Precontemplation is when there is no thought given for changing, 
contemplation is the consideration of change (weighing of the pros and cons), preparation is 
the commitment and planning to change, action is the modification of behaviors, and 
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maintenance is when the substance abuser sustains the changes made.  Change is presented in 
a sequential pathway from precontemplation to maintenance; however change rarely occurs 
so simply or neatly.  Often change is characterized by regression, relapse and repetition of 
stages (DiClemente, 1999). 
Progress   
 
 
  
 
 
 
 
           Relapse 
 
Adapted from Prochaska & DiClemente 1983. 
 
Figure 1.   Transtheoretical Model of Change. 
Self Determination Theory (SDT) 
 The Transtheoretical Model of Change represents a way that recovery from substance 
use is conceptualized.  A second important theory that is essential to the understanding of 
Motivational Interviewing is Self Determination Theory (SDT).  This theory is a broad 
framework for the study of human motivation and personality.  Within SDT, intrinsic and 
extrinsic sources of motivation, are defined and the respective roles of intrinsic and extrinsic 
motivation are described in cognitive and social development, and in individual differences.   
Three conditions are identified that support an individual’s experience; autonomy, 
Precontemplation 
Contemplation 
Preparation 
Action 
Maintenance 
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competence and relatedness (Ryan & Deci, 2000).  Self Determination Theory also proposes 
that the degree to which any of these three psychological needs is unsupported or undermined 
within a social context will have a detrimental impact on wellness in that setting.  This 
framework has broad implications for understanding the practices that enhance, versus 
diminish functioning of the individual (Ryan & Deci, 2000). 
Self Determination Theory can be utilized as a theoretical framework for 
understanding the role and nature of motivation in substance abuse treatment.  According to 
SDT, individuals have a psychological need for autonomy.  Undermining personal autonomy 
makes them feel as if their behavior is coerced, which reduces their interest and motivation to 
engage (in treatment).  The application of SDT to substance abuse treatment predicts that the 
perception of pressure to enter or remain in treatment that is exerted by an external sources 
can be perceived as undermining autonomy.  This theory supports the use of treatment and 
treatment engaging services that seek to enhance patient motivation to engage in treatment, 
thereby reducing external pressure and enhancing autonomy. 
Motivation has been conceptualized in many different ways, with the majority of 
researchers and health care professionals treating motivation as something that varies in 
amount, and therefore, trying to identify and explore conditions that enhance or decrease 
motivation.  While SDT acknowledges the importance of this distinction, the theory goes 
further by considering that people can be moved into action by a number of different forces, 
ranging from self-determined inwardly endorsed motives, including personal interests 
(intrinsic motivation), to external and controlling forces that pressure the individual to 
behave in a certain way (extrinsic motivation).  Considering these forces, SDT has been able 
to identify six distinct types of motivation, ranging from intrinsic motivation to external 
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motivation (i.e., external regulation, introjections, identification and integration) and 
amotivation.  Each of these motivational types is theorized to result in different outcomes, 
even when the level of motivation is high (Ryan & Deci, 2000; Williams, Saizow, & Ryan, 
1999).  
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(Ryan & Deci, 2000). 
Figure 2.  Self Determination Theory 
A major obstacle identified in the treatment of substance abusers is the lack of 
motivation or ambivalence toward treatment (Miller & Rollnick, 2002; Battjes, Onken, & 
Delany, 1999).  Assessing motivation presents a significant challenge, especially when the 
many factors and influences on a person’s motivation (e.g. internal thoughts, external forces) 
are taken in to account.  There is a large body of research to support the importance of 
motivation in treatment seeking behaviors, treatment engagement, retention and treatment 
outcomes (Neff & Zule, 2002; De Leon, Melnick, & Kressel, 1997; Lemke & Moos, 2002).    
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Currently, there is not a standardized terminology to describe the variety of complex 
and nuanced motivations for treatment.  Terminology such as coerced (Wild, 2006; Klag, 
O’Callaghan, & Creed, P., 2005; Sullivan et al., 2008), mandated (Wild, 2006), 
institutionally pressured (Polcin & Beattie, 2006), externally motivated (De Leon et al., 
2001) and socially controlled (Wild, 2006) permeate the literature.  According to Wild 
(2006), this lack of consistent and agreed upon definitions has allowed researchers to operate 
under the assumption that referral source adequately assesses the motivation into treatment.  
Wild (2006), goes on to argue that in order to truly understand motivation, the referral source 
and client perceptions must be independently measured.  This argument has merit as it seeks 
to provide and understand the more nuanced view of treatment engagement, however, it only 
breaches the surface of the complexity.  Future research may benefit from utilizing this more 
intricate understanding of motivation, however, current and past studies have focused solely 
on method of treatment entry (i.e. legally mandated vs. non-mandated).   
Motivation is generally broken into as two distinct types: intrinsic and extrinsic.  
These types of motivation are in reference to the origin of the individuals desire to engage in 
a particular behavior or treatment (Curry, Wagner & Grothaus, 1990).  Intrinsic motivation is 
generally defined as behaviors and desires which are internal to the person (Deci & Ryan, 
1985).  On the other hand, extrinsic motivation refers to “perceived outside pressures or 
coercions to change, or to enter and/or remain in treatment” usually through legal, health, 
family or employment pressures (De Leon et. al., 2001, p. 145).  Wild (2006), identifies 3 
types of social pressure which he defines as social control strategies; legal (i.e. drug court, 
probation, etc.), formally initiated (i.e. outside the legal system but still including 
institutional strategies for facilitating treatment), and informal social controls (persuasive 
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interpersonal tactics).  It is important to acknowledge that legal coercion is not the only type 
of social pressure and can be conceptualized as one of three large categories.  Despite this, 
both intrinsic and extrinsic motivations can effect an individual’s participation in treatment 
with the majority of research into extrinsic motivation focusing on legal pressures.   
Treatment for substance abuse involves meeting the needs of voluntary and mandated 
clients, and for people who may be extrinsically motivated into treatment, raising their 
motivation for treatment (Lincourt, Kuettel, & Bombadier, 2002).  There is evidence to 
support that people’s perceptions of having choice, control and, self-determination over their 
behaviors perform better, are more persistent (Deci & Ryan, 1991; Sheldon, Ryan, 
Rawsthorne, & Ilardi, 1997) and are more motivated and interested in substance abuse 
treatment (Koestner & Losier, 1996; Wild, Enzle, Nix, & Deci, 1997).   
Motivational Interviewing 
 Motivational Interviewing (MI) was developed in a parallel manner to the 
transtheoretical model of change.  While MI was not ‘based’ on this model, both MI and the 
transtheoretical model of change identified that the substance use was not a static construct.  
Substance use is not a constant and unchanging behavior, instead it is a dynamic process 
through which people progress.  This understanding of progression and movement within 
stages allowed for the development of interventions that sought to move people through 
stages and facilitate the already present changing nature of substance use (Miller & Rollnick, 
2009). 
Motivational Interviewing was first presented by Miller and Rollnick (1991) in 
"Motivational Interviewing, Preparing people for change".  They define MI as a “directive, 
client centered counseling style for eliciting behavior change by helping clients to explore 
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and resolve ambivalence” (Miller & Rollnick, 1991, pp. 25).   Further, Motivational 
Interviewing is described as a skillful clinical method, and style of counseling and 
psychotherapy rather than a set of techniques.  Motivational Interviewing can employ a 
number of specific tasks/exercises but is not solely classifiable by these techniques. Instead 
MI stresses the importance of collaboration between the therapist and the client (Miller & 
Rollnick, 2002).  According to Miller and Rollnick (2002), an underlying motivational spirit 
to MI encompasses several key ideas, including collaboration, evocation, and autonomy.   
The collaborative relationship between practitioner and client is an integral 
component of any MI-based intervention.  This relationship actively avoids the authoritarian 
stance employed in many treatment seeking relationships, and instead encourages a partner-
like relationship.  Each individual (both the clinician and the client) brings specific expertise 
to the treatment.  This creates a positive, not coercive, interpersonal atmosphere that is 
conducive to change. 
Through the process of evocation, the therapist helps to elicit information or feelings 
from the client.  In the spirit of the collaborative relationship in MI, the therapist avoids the 
role of imparting, instilling or installing, and instead works with the individual to identify 
their own motivation.  To be effective, the relationship requires the drawing out of 
motivation from the individual.  Miller and Rollnick (1991), also express the importance of 
finding intrinsic motivation for change within the individual and evoking it from the person. 
A final core component to the ‘spirit’ of MI is autonomy.  Responsibility for change 
lies within the client.  The individual client must present the motives and arguments for 
change.  They cannot be made to do anything or forced to change, if there is any hope of long 
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term or internal change.  This type of therapeutic intervention is self direction of the client, 
by the client, and for the client. 
Four general principles are integral to MI: expression of empathy, development of 
discrepancy, rolling with resistance, and supporting self-efficacy.  While several exercises 
can be used to demonstrate these principles, the exercises do not define them.  Expression of 
empathy is a fundamental and defining characteristic of MI.  Founded on Carl Rogers’s work 
of reflective listening and accurate empathy (Hettema, Steele, & Miller, 2005) this skill is 
utilized throughout the entire MI encounter.  It is through empathy that the counselor can 
achieve understanding of the client without judgment, criticism or blame.  Expressing 
empathy does not require agreement with the client’s reporting, only acceptance by the 
clinician that the client’s perspective is a valid view point within the client’s personal 
framework, regardless of whether the same perspective  is held by the therapist.  As Miller 
and Rollnick say, this “attitude of acceptance and respect builds a working therapeutic 
alliance and supports the client’s self-esteem, which further promotes change” (Miller & 
Rollnick, 2002, pp. 37).   
Motivational Interviewing encourages an intentionally directive approach.  The 
development of discrepancy is the means by which the therapist attempts to help amplify 
discrepancies between a client’s present state, and how they want to be.  The clinician may 
also amplify the differences between the client’s behaviors and their broader goals and 
values.  The challenge for the clinician in developing discrepancy is that there may be such 
an enormous gap between where a client is, and where they want to be, that this discrepancy 
actually becomes de-motivational.  Generally, when developing discrepancy, the client is 
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prompted to identify reasons for change.  Having the client report on personal motivation for 
change is more effective than the clinician saying it for them.   
Many traditional substance abuse treatment models identify client resistance as 
“denial”.  This therapeutic hurdle usually triggers a therapist to advocate for change, while 
the client advocates equally as loud, or louder, for the status quo.  Conversely, MI stresses 
that therapists must “roll with resistance” in an effort to reframe client resistance and move 
toward the direction of change.  The therapist’s role is not to provide answers, but to help 
elicit answers from the client.  The client is identified as the expert on themselves, and as 
such, they are in possession of important insight and solutions to their own problems. 
The final principle of MI is the support of self-efficacy.  Self-efficacy is the 
enhancement of an individual’s confidence to succeed, identify and manage their own 
problems, and successfully develop solutions to these problems.  Support comes from the 
therapist’s belief in the client and his/her intrinsic ability to make changes.  It is important to 
remember that it is not the therapist doing the change.  The therapist is affirming the client’s 
ability and providing a voice of encouragement.  For example, being supportive of changes in 
behavior that the client is willing to make. 
Motivational Enhancement Therapy (MET) 
Motivational Enhancement Therapy (MET) is the systematic implementation of the 
principles of MI and Prochaska and DiClemente’s (1983), Stages of Change theory.  It is 
designed to produce rapid, internally-motivated change.  Motivational Enhancement Therapy 
(Miller & Rollnick, 1991; Miller et al., 1992) incorporates elements found in successful brief 
intervention strategies, summarized by the acronym FRAMES: Feedback regarding personal 
risk, negative consequences, or impairment related to substance use; emphasis on personal 
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Responsibility to change; the provision of clear Advice to change; presentation of a Menu of 
change options; an Empathic therapist style; and facilitation of the patient’s Self-efficacy. 
 Motivational Enhancement Therapy is a manualized treatment that was developed, 
using MI principles, for Project MATCH, one of the largest studies to date looking at 
multiple treatments for alcohol problems (Project MATCH Research Group, 1997a,b, 1998).  
Project MATCH was a multi-site, randomized clinical trial conducted at ten sites across the 
U.S., which sought to compare Twelve-step Facilitation Therapy (TSF), an approach based 
on the principles of Alcoholics Anonymous; Cognitive-behavioral Coping Skills Therapy 
(CBT), an approach based on social learning theory; and Motivational Enhancement Therapy 
(MET), a less intensive form of therapy based on the principles from Motivational 
Interviewing.   MET was developed and manualized from the underlying MI intervention in 
order to ensure fidelity of the intervention across participating sites. 
 Project MATCH found that the three interventions (TSF, CBT and MET) were 
equally effective at decreasing alcohol consumption and days drinking, even though TSF and 
CBT were delivered over 12 weekly sessions, compared to 4 MET intervention sessions over 
a twelve week period.  MET was found to be a significantly briefer intervention with 
outcomes consistent with more intensive and ‘established’ treatments.  Additionally, better 
outcomes were noted for clients with lower “readiness to change” (i.e. pre-contemplation, 
contemplation) in terms of the transtheoretical stages of change stages model (described 
previously) with MET than with CBT, whereas the reverse would apply to those who had 
reached the action stage of change (Project MATCH Research Group, 1997a). 
The MET intervention was slightly modified for the recent CTN004 protocol, to, 
consist of three carefully planned sessions.  Session one is described as focused on reviewing 
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an individualized Personal Feedback Report, which is created through summarization of 
objective information and client report at intake, and serves as a means of summarizing the 
client’s view of substance-related problems, consequences, and reasons for quitting The 
second and third sessions are then focused on discussing plans for changing substance use 
(Carroll et al., 2002). 
Prevalence Rates Among Correctional Populations 
Among correctional populations a disproportionate number of individuals with 
substance use disorders exist.  These numbers can be seen to reflect the “War on Drugs” 
mentality of the United States law enforcement system (Miller & Carroll, 2006).  
Correctional populations include a variety of individuals who are involved with the 
correctional system at any level, including people who are incarcerated or received a deferred 
judgment, probation or parole.  In their review of substance abuse among men and women 
entering prison, Fazel, Bains & Doll (2006), found prevalence rates many orders of 
magnitude higher than in the general population, with estimates of alcohol abuse and 
dependence rates for male prisoners ranging from 18 to 30% , and in female prisoners 
ranging from 10 to 24%.  Drug abuse and dependence rates ranged from 10 to 48% in male 
prisoners and 30 to 60% in female prisoners (Fazel, Bains & Doll, 2006).    These numbers 
are considerably higher than the estimated 11.9% of males and 6.1 % of females with 
substance abuse and dependence, in the general population (SAMHSA, 2010b).   
The National Criminal Justice Treatment Practices (NCJTP), a national survey of 
adult offenders in prisons, jails and community correctional agencies, estimates that 7 million 
(BJS, 2004) to 8 million (Taxman, Young, Wiersema, Rhodes, & Mitchell, 2007) adults are 
under correctional control.  Of those, probationers accounted for 75% to 85% of all persons 
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under correctional control in 2005 (Taxman, Perdoni, & Harrison, 2007).   According to the 
Bureau of Justice Statistics there were 3,296,513 men and women on probation at the state or 
federal level as of 1/1/1998.  In 1998, the number of individuals on probation increased by 
3.7% to 3,417,613 (BJS, 1998).  By 2008, the rates of probationers had risen to 4,270,917, 
with parolees accounting for an additional 828,169 individuals, totaling nearly 5.1 million 
individuals under correctional control in community supervision settings (BJS, 2009). 
While on probation, many offenders continue to use illegal substances. Isaac, Heatley 
& Savoie (1998), found that 36% of probationers and parolees tested positive for illicit 
substances, 43% percent had used some type of illicit drug the past year, and 28% had used 
an illicit drug within the past month. The most common illicit drug used was marijuana; 23% 
of probationers had used it within the past month. Cocaine (9%), psychotherapeutics (6%), 
and hallucinogens (5%) were the next most commonly used illicit drugs. These drugs, as well 
as most other illicit drugs, were used at much higher rates among probationers than they were 
among the general population. (Brittingham, Schildhaus, & Gfroerer,  1999)) 
Studies have shown that without treatment, substance-abusing offenders will 
invariably repeat the same types of behaviors that led to their criminal justice status 
(Harrison, 2001).  Among the nearly 300,000 prisoners released in 15 states in 1994, 67.5% 
were rearrested within 3 years and 51.8% were back in prison (Langan & Levin, 2002). 
Approximately half of those who ended up back in prison did so for technical parole 
violations (e.g., failing a drug test and missing an appointment with their parole officer).  The 
Drug Abuse Treatment Outcome Study (DATOS) found that more than 42% of the clients 
enrolled in publicly funded drug abuse treatment programs were from the criminal justice 
system (Craddock, Rounds-Bryant, Flynn, & Hubbard, 1997). It is likely that the number of 
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offenders engaging in community treatment drug abuse programs has risen since this study 
was conducted, however, more current data are unavailable.  Offenders tend to participate in 
traditional community outpatient programs that consist of drug education and counseling 
services. There is considerable focus on increasing treatment services received, with much 
less discussion about how to provide these services effectively (Craddock, Rounds-Bryant, 
Flynn, & Hubbard, 1997). 
Existing Approaches with Substance Use in Correctional Populations 
There are a number of programs and approaches that address substance use in 
correctional populations.  One such program is probation and parole.  Through this 
mechanism, former prisoners are released from prison and are required to adhere to strict 
behavioral guidelines, including abstinence from illicit substances.  If they are unable to 
remain abstinent they receive harsh sanctions or return to prison.  These programs operate 
under the general principle that by providing negative incentives for using that these 
behaviors will not happen (Lawrence, 2008). 
Another approach available for correctional populations is jail based substance abuse 
treatment, often times focusing on twelve step substance abuse support.  These programs 
operate in many prisons and are a way for individuals who are trying to remain abstinent 
from substances can receive peer support to maintain their abstinence (Hedden, Guard, & 
Arndt, 2011). 
An additional program that seeks to address specific treatment needs of correctional 
populations is drug court.  Drug Courts, first introduced in 1989, have been utilized as a 
means of diverting substance offenders from the traditional court system into a specific Drug 
Court system which utilizes sanctions (Wilson, Mitchell & MacKenzie, 2006).  In this system 
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an offender is mandated to treatment, monitored by the court system and has sanctions 
enacted.  Sanctions are enacted for substance use relapse, failure to attend treatment or for 
other infractions (Wilson, Mitchell & MacKenzie, 2006).  These programs are currently 
utilized, or have plans to be enacted, in 50 states, the District of Colombia, Puerto Rico, and 
over 70 tribal locations (Madras, 2010).   
Use of Drug Court programs attempts to tailor how substance abusers are managed 
within the criminal justice system, with different management dependent on the individual’s 
needs.  Still numerous gaps remain in appropriate and effective treatment for mandated 
clients.  It is still unknown if there are differences in effectiveness of treatment for  
populations that seek substance abuse services with or without legal motivation.  Other 
informational gaps include questions regarding if mandated individuals will respond more 
favorably, with decreased substance use, than more traditional treatment seeking populations. 
MI/MET Research 
Motivational Interviewing and MET have substantial research literature supporting 
their efficacy and establishing their role as an Evidence Based Practice (EBP).  In addition to 
being supported in the literature, they have also been established as brief interventions (BI) 
designed to enhance an individual’s motivation to change problem behaviors.  A significant 
research base exists supporting the efficacy of MI with a variety of substance using 
populations, including: cocaine (Stotts, Schmitz, Rhoades, & Grabowski, 2001), heroin 
(Saunders, Wilkinson & Phillips, 1995; Ward, Mattick & Hall, 1992), marijuana (The 
Marijuana Treatment Project Research Group, 2004; Stephens, Roffman & Curtin, 2000) and 
multiple substances (Carroll, Libby, Sheehan, 2001;  Martino, Carroll, Malley, & 
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Rounsaville, 2000).  Additionally, MI/MET represents one of the primary EBP’s for 
treatment of substance use disorders.   
Motivational Interviewing was initially conceptualized for use with alcohol related 
disorders and as such, has a substantial research base with this population (Brown & Miller, 
1993; Bien, Miller, & Tonigan, 1993; Miller & Rollnick, 2002).  In their study looking at the 
impact of MI on treatment participation and post-treatment alcohol consumption, Brown and 
Miller (1993), found a significant beneficial effect.  In this study, participants were 
randomized to treatment as usual (TAU) or a two session MI assessment and interview at 
intake in addition to standard treatment procedures.  Therapist rating of patient treatment 
involvement was shown to be significantly higher for the MI intervention group.  There was 
also a significant treatment effect at post treatment (3-month follow up), showing that the MI 
group achieved more favorable outcomes (64% less substance use compared to 29% in the 
control group).  While the three month follow up period was not a long enough period to 
establish if there were enduring effects on drinking behavior, it is suggestive of a positive 
long-term outcome.  
In the original multi-site clinical trial (Ball et al., 2007) from which this secondary 
data analysis was carried out, 461 adults who abused substances were randomized to receive 
either MET as adjunct to Treatment as Usual (TAU) or TAU alone (i.e., standard treatment).  
Findings from the study showed a significant reduction in substance use across both 
interventions during the 4-week therapy phase.  Post-intervention, MET sustained these 
reductions while CAU showed a significant increase in substance use over this same follow 
up period.  Study findings supported the superior treatment effects of MET in a real world 
setting across 5 treatment sites. 
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Utilization of the skills or “spirit” of MI is integral to the successful administration of 
MI.  A study comparing three treatment approaches: confrontational, client centered, and 
control (treatment as usual), found that the client centered approach (which adhered closely 
to MI) was significantly more effective at reducing substance use than the control or 
confrontational groups (Miller, Benefield, & Tonigan, 1993).  These effects were present at 
both 6 weeks post treatment and, through collateral report, at 12-month follow up.  These 
results continue to support the utility of, and lasting effects of MI when implemented within 
an alcohol using population.   Further, findings supported the relationship between 
confrontational approaches and patient drinking at the 12-month follow up.  This study, and 
the previous ones, are good examples of the existing research conducted with MI, and 
supports the efficacy of MI with alcohol using populations.   
 In a relatively small (N=23) pilot study conducted by Martino et al. (2000), with 
individuals diagnosed with drug dependence and concurrent mood or psychotic disorders, 
participants were randomized to receive either a standard intake or a 45-60 minute 
motivational interview at intake.  Although no significant differences in substance use were 
observed, the MI group demonstrated higher rates of attendance through 3 month follow-up.  
These findings support the efficacy of MI at improving treatment engagement.  
 A multisite randomized clinical trial conducted by The Marijuana Treatment Project 
Research Group (2004), compared a two session MET intervention with a nine-session multi-
component intervention and a delayed treatment control group.  Results indicated that both 
the two-session MET and nine-session multi-component interventions were significantly 
more effective than the control.  While the longer multi-component intervention showed the 
greatest decreases in marijuana use, statistically significant reductions in frequency of 
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marijuana use and dependence symptoms were also observed for the briefer, two session 
MET condition when compared to the control.  Similarly, in their brief study of opiate users 
attending a methadone maintenance program, Suanders and colleagues (1995), found that 
participants randomized to brief MI intervention (N=57) reported significantly greater 
increases in commitment to abstinence, fewer opiate related problems, better compliance 
with methadone program and longer abstinence rates than those randomized to an 
educational control (n-65).  Moreover, considerably higher attrition rates at 6-month follow 
up were noted for the educational group (49%) as compared to the MI group (30%).  Less 
favorable results were achieved for increasing or maintaining self-efficacy in the MI 
condition, though this may be due to lack of follow through on treatment interventions for 
individuals that were seeking additional treatment services. 
A number of meta-analyses have done an exceptional job of looking at the MI 
literature. One such analysis was conducted by Burke, Arkowitz and Menchola (2003), 
reviewed 30 studies that had utilized adaptations of motivational interviewing (AMI).  
Results found greater reductions in problem behaviors in  AMI’s when compared to no-
treatment or placebo controls, there was a significant reduction in problem behaviors, but 
when compared to previously established effective treatments there was no difference.  In the 
15 studies that were specific to alcohol and drugs, there was a significant effect when 
compared to no treatment or placebo groups, but not when compared to other active 
treatments.  However,  AMI’s were, on average, 180 minutes shorter than traditional active 
treatments and resulted in the same effect.  This suggests that AMI’s are as effective as other 
treatments, and because they can be conducted in a shorter time period, may be more 
palatable for implementation.  Variability in the effectiveness of AMI’s across problem 
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behaviors was also noted, with medium effects observed for drug addiction (0.56) and diet 
and exercise (0.56), and small to medium (0.23 to 0.53) effects for alcohol.).  Treatment 
effects appeared to have consistent durability at follow up. 
In their meta analysis of 119 studies targeting outcomes of substance use (tobacco, 
alcohol, drugs, and marijuana), health-related behaviors (diet, exercise, safe sex), gambling, 
and engagement in treatment, Lundahl, Kunz, Brownell, Tollefson and Burke, (2010) found 
consistently small but significant positive effects of MI across a wide range of substances.  
The majority of studies reviewed in the analysis related to substance use, which is not 
surprising given the origination of MI, however significant results were not limited to this 
field, and positive results were observed across all identified areas.  Motivational 
Interviewing was supported as more effective than non-specific treatments, and, while not 
necessarily better than CAU, in some cases it was at least as good.  Effects of MI were 
observed to be durable up to two years post intervention, and beyond in some cases. 
 Although the research on the effectiveness of MI/MET among legally mandated 
participants is limited, findings that do exist, are encouraging.  One existing study is a pilot 
conducted by Lincourt et al. (2002), which looked at mandated clients for a 6 session group 
based MI grounded intervention.  The researchers were concerned that clients were not 
benefiting from CAU, had a high level of resistance and were prematurely ending treatment.  
Looking specifically at a group of clients who were unable to identify a problem upon 
entering treatment (n=167), participants were assigned to receive either MI plus standard 
treatment (n=75) or standard treatment only (n=92).  Though not randomized, the groups 
were equivalent on age, sex, years of education, proportion of those married, and ethnic 
makeup.  Participants in the MI group were significantly more likely to complete treatment 
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than those taking part in standard care alone.  Within the MI group, self-report of motivation 
significantly increased from baseline to follow-up, and treatment participation and 
completion rates were nearly double that of the standard care group.  Overall, it was 
suggested that motivationally based interventions, especially group, may be beneficial for a 
mandated client population. 
Harper & Hardy (2000), examined the effectiveness of utilizing MI with clients in a 
probation setting, and found that while there was improvement noted across all conditions, 
those in contact with probation officers trained in MI techniques exhibited statistically 
greater improvements across all conditions.  Stevens et al. (2006), looked at a European 
sample of Quasi-Compulsory Treatment (QCT) participants and found that in the face of this 
research, it has been suggested that people who are coerced into treatment will not be 
motivated to change (Cahill, Adinoff, Hosig, Muller & Pulliam, 2003) and thus less likely to 
engage and succeed in treatment (DiClemente, Belluno & Nevins, 1999).  Despite these 
concerns there exists a promising, if limited, research in support of utilizing motivational 
treatments among legally mandated clients.   
The above findings support the efficacy of MI within a variety of populations across a 
range of settings.  Additionally, the results are supported as durable and at least as good as 
existing treatments.  An additional strength of MI is its effectiveness as a standalone BI.  
Swanson, Pantalon, & Cohen (1999), and Martino et al. (2000), reported that a single session 
of motivational interviewing was associated with better treatment compliance and retention 
for dual-diagnosis participants compared with treatment as usual in inpatient and day 
treatment settings, respectively. A multisite trial of 450 marijuana-dependent participants 
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found that two sessions of MET was significantly more effective than a delayed-treatment 
control condition in reducing marijuana use and related outcomes (Babor, 2004). 
An additional strength of MI is its use as an adjunct for facilitating engagement and 
retention in more traditional drug treatment programs (Saunders, Wilkinson, & Phillips, 
1995; Aubrey, 1998; Lincourt, Kuettel, & Bombardier, 2002; Krupski, Sears, Joesch, Estee, 
He, Dunn, Huber, Roy-Byrne, Ries, 2010).   MI also appears to be differentially effective 
with clients who are more angry and resistant, or less ready for change (Project MATCH 
Research Group 1997). This is consistent with the original intent and theoretical rationale for 
MI. A study conducted in a community treatment program found that a single session of 
MET, delivered by staff members who received only brief (single day) training, doubled the 
rate of treatment initiation compared to the standard evaluation among drug-abusing parents 
referred to treatment through the child protection system (Carroll, Libby, & Sheehan, 2001). 
Saunders et al. (1995) reported that a single session of motivational interviewing for 
participants entering a methadone maintenance program resulted in clients’ greater 
commitment to abstinence and fewer opioid-related problems over a 6-month follow up 
period. 
While there is much research in support of the efficacy of MI as a treatment strategy, 
considerable variability exists with regard to implementation in implementation, longevity 
and training.  There is still room for improvement in our understanding of what makes MI 
work and with whom, and a greater understanding of these questions will allow for the 
optimal implementation of this effective intervention. In Project MATCH, the relative 
efficacy of an MI-based intervention varied significantly across sites and therapists despite 
extensive efforts to standardize training and treatment procedures (Project MATCH Research 
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Group 1998). Thus, it appears that variation in the delivery of MI can have substantial impact 
on its outcome.   
Statement of Problem and Hypotheses 
A wide range of studies have examined the efficacy of MI and MET in a range of 
settings with an array of target populations (Bien et al., 1993; Steinberg et al, 2002; Stotts et 
al. 2001; Carroll et al., 2001; Martino et al., 2000; Martin et al. 2006; Winhusen, Kropp, 
Babcock, Hague,  Erickson, Renz, et al. 2008).  Despite numerous articles in support of 
utilizing MI, little research has focused on the variations in the efficacy of MI in different 
treatment populations.  While MI has demonstrated success with a range of problem areas 
(i.e. substance abuse, smoking cessation, gambling, etc.), and across broad population groups 
(i.e. adults, adolescents, pregnant women, etc.), less is known about MI’s success within such 
broad subgroups.   
There is a significant controversy in the general population, criminal justice 
community and treatment communities on how best to engage individuals who are legally 
motivated to participate in treatment.  This controversy will not be resolved without further 
research.  To date, little research has been devoted to the role of MI in engaging individuals 
are legally motivated to treatment.   A legal mandate for treatment, depending on the 
individual, represents a variable degree of encouragement to attend, participate and make 
changes in behaviors.  Motivational interviewing by its very nature and design may be an 
ideal way to engage and work with legally mandated individuals.  Given the frequency of 
legal involvement among individuals suffering from substance abuse and dependence this 
gap represents a significant limitation in the existing research. 
28 
 
The few studies that have examined this potentially significant variation in substance 
using populations have yielded mixed results.  For example, Project MATCH found limited 
statistically significant outcomes for treatment matching, while Lincourt, Kuettel and 
Bombardier (2002), observed increased attendance and completion among court ordered 
participants in a MI group program.   Unfortunately these studies also differ 
methodologically in ways that make comparisons across studies difficult.  At this time there 
is a need for further research to help unravel the inconsistency and shed new light on the 
subject of MI and it’s applications with legally mandated individuals. 
The current study used data collected from a multi-site study of MET with diverse 
patient groups and had two specific aims.  First, using legal status as an indicator of 
motivation (legally incentivized vs. non-legally incentivized) to attend treatment, those with 
and without legal incentive were compared on distinct variables (e.g. demographics, primary 
substance, etc.).  Second, using legal incentive status we compared outcome variables of 
treatment retention and substance use frequency (at weekly time points). 
Data Checking. Treatment effects will be observed for both treatment groups (MET 
and TAU).  A reduction in primary substance use during the experimental phase of treatment 
will be observer for both treatment conditions.  A mixed linear model will be conducted to 
examine the effectiveness of the interventions (MET vs. TAU) through experimental 
treatment completion (Baseline through Week 4) and the effectiveness of the interventions 
(MET vs. TAU) at post intervention follow-up (Week 4 through week 16).   
Hypothesis 1.  When participants randomized to either MET or TAU are further 
subdivided into those with and without legal incentives to enter substance abuse treatment, it 
is hypothesized that those in the MET with legal incentives group will have the most positive 
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treatment outcomes (greater reduction in days per week of primary substance use; higher 
rates of treatment retention at 16 weeks) over time relative to the other three participant 
subgroups.  Analyses will be conducted to assess the effects of Treatment Group and Legal 
Status on two outcome variables, primary substance use (baseline through 16 weekly data 
points) and treatment retention (active in treatment at study completion [y,n]).   
Hypothesis 2. When participants randomized to either MET or TAU are further 
subdivided into those with primary alcohol or primary drug and with and without legal 
incentives to enter substance abuse treatment, it is hypothesized that those in the MET 
intervention presenting with primary alcohol problems and legal incentives will have the 
most positive treatment outcomes over time relative to the other participant subgroups.  
Hypothesis 3. When participants randomized to either MET or TAU are further 
subdivided into those with high and low motivation to enter substance abuse treatment, it is 
hypothesized that those in the MET with low motivation group will have the most positive 
treatment outcomes (greater reduction in days per week of primary substance use; higher 
rates of treatment retention at 16 weeks) over time relative to the other three participant 
subgroups.   
Methods 
Participants 
The present study utilized data from a multi-site randomized clinical trial conducted 
under the auspices of the NIDA Clinical Trials Network (CTN).  Recruitment occurred at six 
community treatment programs and clients providing informed consent were randomized to 
receive either motivational enhancement therapy (MET) or treatment as usual (TAU) during 
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the first 4 weeks of drug abuse treatment.  Substance use and related outcomes were assessed 
at baseline as well as 8 and 16 weeks post randomization.   
Study Subject.  Subjects were (n=461) clients admitted to one of the six participating 
community treatment programs who met study inclusion criteria and consented to research 
participation.  Participants were predominantly male (70.9%); minority (58%); never married 
(81.6%); with a mean age of 34.8 (SD=10.2).  
Study Sites.  For this multi-site protocol, substance abuse treatment programs were 
chosen from the network of community providers participating in the NIDA Clinical Trials 
Network (CTN).  Only outpatient programs were eligible for this particular protocol.  To 
achieve adequate numbers of study participants, six community treatment programs (CTPs) 
were chosen.  The final cadre included rural, urban and suburban sites and represented the 
States of California, Connecticut and Pennsylvania.  
Patient Ascertainment.  To maximize sample diversity and representativeness, study 
inclusion and exclusion criteria were kept to a minimum.  To be included in the study, 
individuals had to:  1) be seeking outpatient substance abuse treatment; b) be at least 18 years 
of age; and c) meet recent substance use criteria (past month).  Excluded were persons found 
medically or psychiatrically unstable (could not provide informed consent) or those enrolled 
in residential care, methadone maintenance or a medical detoxification only program of care.  
Study Procedures 
Study recruitment took place over a 37-month period from June, 2001 to July, 2004. 
The flow of participants from screening and informed consent through 18-week follow-  up 
assessment is shown in Figure 3. 
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Diagram of eligibility, enrollment, treatment and follow up rates.  TAU = treatment as 
usual; MET = motivational enhancement therapy 
Figure 3.  CONSORT Diagram of Eligibility, Enrollment, Treatment and Follow up Rates.   
 
 
 
 
Screened  (n = 683) 
Met eligibility criteria and provided 
informed consent  (n = 496) 
Completed baseline assessment and 
were randomized  (n = 461) 
MET  (n = 216) TAU  (n = 245) 
Completed post intervention       
follow up  n = 151 
Completed post Intervention      
follow up  (n = 163) 
Completed follow up 1 (8 weeks post 
randomization) (n = 143) 
Completed follow up 1 (8 weeks post 
randomization)  (n =156) 
Completed follow up 2(16 weeks post 
randomization)  (n = 166) 
Completed follow up 2 (16 weeks 
post randomization)  (n=149) 
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           Screening.  Patients seeking admission to one of the six participating outpatient CTPs 
learned about the study through posted flyers, their counselors or an on-site Research 
Assistant (RA).  Those wanting more information (N=683) met with the RA who explained 
the purpose of the study and answered any questions they might have.  Patients who were 
eligible for the study were informed that participation was voluntary and a decision not to 
participate would have no negative impact on their treatment at the CTP.  Also, they were 
told they could discontinue their participation in the study at any time with no negative 
consequences to themselves or their substance abuse treatment.   
If a person indicated they were not interested in the study, they were referred to their 
counselor at the CTP for appropriate care or referral.  If instead they wished to be in the 
study, the RA proceeded to obtain written informed consent and proceeded with baseline 
assessment. 
           Informed Consent.  Potential study participants were told about the study by RAs 
who successfully completed all required training, including the training in human subjects 
protections, Good Research Practices (GRP), through the Training Subcommittee of the 
NIDA CTN.  RAs were closely monitored with on-site supervision and corrective action 
when necessary.  As described above, RAs provided potential subjects with an overview of 
the study, then read the consent form aloud, verbatim, stopping to clarify and answer 
questions as needed.  RAs made sure potential study participants understood their 
participation would be voluntary and a decision not to participate would have no negative 
consequences on their standard treatment at the CTP.  For persons interested in study 
participation, the RA witnessed signing of the consent form.  The participant was given a 
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copy of this form (co-signed and dated by the RA) and the original was stored in a locked file 
cabinet separate from the participant’s research data.   
           The study protocol was reviewed and approved by the Institutional Review Boards 
(IRBs) of all participating Universities and their CTP affiliates prior to implementation.  In 
addition, a Data Safety Monitoring Board (DSMB) was convened by the National Institute on 
Drug Abuse (NIDA).  The national DSMB monitored study progress and reviewed adverse 
events throughout the course of the study.   
           Baseline Assessment.  Baseline assessment required approximately 2 hours to 
complete and typically took place on the same day as study recruitment.  Assessment 
measures included:   demographic form, University of Rhode Island Change Assessment 
(URICA, Treatment Attitude and Expectations, Substance Dependence Severity Scale 
(SDSS), Addiction Severity Index (ASI-‘lite’), Substance Use Calendar (SUC), Short 
Inventory of Problems-revised (SIP-R), Treatment Utilization Form (TUF), urine test, 
breathalyzer 
           Random Assignment.  Randomization to either the MET or TAU intervention group 
occurred following completion of baseline assessment.  To balance groups on demographic 
and other key variables, URN randomization was used.  URN variables included:  gender 
(male, female), race (Caucasian, African American, Hispanic, Asian, Other), primary drug of 
abuse (cocaine, methamphetamine, alcohol, opioids, marijuana, benzodiazepines, other), 
mandated to treatment (yes, no), and currently employed (yes, no). 
Study Arms.  Participants in this study were randomly assigned to ‘treatment 
condition’ where they received 3 sessions of either MET or TAU, with the latter defined by 
each local CTP. 
34 
 
TAU Intervention.  Participants randomized to the control group received three 
sessions of individual counseling as is usually provided at that CTP.   Sessions were between 
45-55 minutes each and were provided during the four week active phase. Sessions were not 
standardized across sites, but were allowed to vary according to standard clinical procedures 
of each individual CTP.  Clinicians “collected information on substance use and psychosocial 
functioning, explained treatment program requirements, discussed the participant’s goals for 
treatment, provided early case management and substance use counseling, encouraged 
attendance at 12-step meetings, promoted abstinence, and emphasized follow through with 
treatment at the clinic” (Ball et al., 2007, p. 559). 
MET intervention.  Participants randomized to the experimental group received 
three sessions of MET from counselors trained by members of CTN staff (Miller & Rollnick, 
1991; Miller et al. 1992).  Each session was between 45-55 minutes long and the 3 sessions 
were scheduled over weeks 1-4 post randomization. First MET therapists reviewed the 
participants individualized Personal Feedback Report (PFR).  This was created using data 
provided during baseline assessment and focused on substance-related problems, 
consequences, and reasons for quitting. Second and third sessions then focused upon 
discussing plans for changing substance use.  Strategies used during MET intervention 
included, but were not limited to, asking open ended questions, avoiding and rolling with 
resistance, listening with empathy, eliciting self-motivational statements, and reframing.   
Therapist Training and Certification.  All counseling staff at participating CTPs 
were eligible to serve as study therapists.  Participation required 1) a willingness to learn a 
manualized version of MET, 2) consent to be randomized to provide either MET or TAU, 
and 3) be willing to have sessions audio taped.  In addition, supervisory staff approval was 
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required.  Therapist volunteers were then randomly selected to receive MET training, the 
others were asked to continue TAU counseling as before.  Fore MET, Training of Trainers 
(TOT) model was used, with one individual from each participating Node serving as the local 
trainer, supervisor, and intervention fidelity monitor.  Node MET trainers were all familiar 
with MET prior to attending the two day “training of trainers” workshop where all Node 
trainers met to rehearse how staff at their respective CTP’s would be trained in the 
intervention.  Following this TOT, Node trainers returned to their sites with MET manuals, 
training materials (video tapes, role plays, slides), and therapists  assigned to MET for the 
Node participated in 16 hours of didactic MET training.   
Fidelity of the MET intervention provided by therapists was maintained through 
regular supervisory meetings, review of audiotapes, and therapist self-monitoring of their 
behavior through Therapist Checklists. During the implementation of the study, each CTP 
supervisor (or Node MET expert) provided biweekly group supervision (in person or by 
phone) and provided individual supervision when it was needed. Supervision included, 
reviewing of audiotapes and providing corrective feedback around the use of prescribed 
versus proscribed techniques from the MET manual. The on-site MET supervisor received at 
least monthly consultation (phone or face-to-face) with the Node MET supervisor regarding 
supervisory issues.  All sessions in the MET condition were audio taped with a sample rated 
by independent evaluators blind to participants’ treatment assignment. 
Standard CTP Services.  Standard treatment offered at each separate CTP, except 
for the 3 individual sessions participants received as part of the study intervention, was not 
otherwise constrained or controlled. That is, if it was standard practice at a CTP for patients 
to attend weekly group sessions in addition to individual counseling, participants in both 
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MET and standard treatment would do so (providing the total number of sessions was equal 
across conditions).  Participation in treatment after the conclusion of the treatment period was 
measured by the Treatment Utilization Form (TUF).   
Follow-up Assessments.  Follow up Assessment Battery:  Follow ups were 
conducted with study participant by the RA at the conclusion of the 4 week intervention 
period and at 8 and 16 weeks post intervention completion.  Follow-up visits took 
approximately 1 hour to complete.  Data were analyzed using intent-to-treat principles, such 
that once a participant was randomized to MET or TAU they were followed and considered 
in outcome analyses. 
Compensation.  Participants were compensated $10 for completing each of the 
assessments (pretreatment, each week during treatment, posttreatment, and each of the two 
follow-ups. Therefore, participants were eligible to receive a total of $70 if they attended all 
seven interviews as scheduled.  
Measures 
The following assessments were completed at baseline and/or follow ups.  All 
interviews were conducted by CTN-trained and certified research assistants. 
Demographic Form. The demographic form collected information about age, 
ethnicity, education level, employment, reason for entering treatment and marital status as 
well as information about present substance use. 
Addiction Severity Index, Version 5 (ASI, McLellan, Kusher, Metzger, Peters, 
Grissom, et al. 1992).  The ASI ‘lite’ is a minor variation (six fewer questions and no 
interviewer ratings) of the ASI, a widely used instrument that assesses seven domains of 
psychosocial functioning commonly effected by alcohol and drug dependence, they are,  
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medical, employment/support, alcohol, drugs, legal, family/social, and psychiatric.  
Participants provide objective data on the number, extent and duration of problem symptoms 
across two time periods: 30 days prior to study enrollment and lifetime (excluding past 30 
days).   
Treatment Utilization Form (TUF). The 11-item TUF records a number and 
duration of substance abuse treatment sessions attended over target periods of assessment 
(Carroll et al., 2001).  Participant involvement in ancillary services (i.e., non-study related 
counseling, child care, medical, psychiatric, vocational, legal and medication services) is 
recorded.  The TUF was adapted and shortened from the Treatment Services Review (TSR; 
McLellan, Alterman, Cacciola, Metzger, & O’Brien, 1992), which has shown to be a reliable 
and valid assessment (McLellan et al., 1992). 
Substance Use Calendar (SUC).  Detailed reports of substance use were obtained 
with the SUC, which was the Timeline Followback method (Sobell and Sobell, 1992; Miller 
and Dleboca, 1994; Fals-Stewart et. al. 2000).  The SUC is administered as a semi-structured 
interview.  In the present study it focused on the following substances, marijuana, cocaine, 
alcohol, methamphetamine, benzodiazepines, opioids, and other drugs).  For the present 
study, the primary outcome measure was created from the SUC.  It was defined as days per 
week using the primary substance of abuse.  Days of use during each of the 16 weeks of post 
enrollment were recorded.  
University of Rhode Island Change Assessment (URICA).  A 32 item, widely 
used, self-report which assesses the participant’s current position regarding readiness for 
change (e.g. precontemplation, contemplation, preparation) with regard to substance use 
(DiClemente & Hughes, 1990; Callahan, Taylor, Moore, Jungerman, Vilela & Bundy, 2008)  
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The URICA when scored, results in 4 composite scores; precontemplation, contemplation, 
action, maintenance.  A readiness to change score ranging from -2 to 14 is created using the 
following formula, contemplation + action + maintenance – precontemplation = Readiness to 
Change score. Factor analysis has supported the four-factor structure in some studies (Carney 
& Kivlahan, 1995), but not in others (Belding, Iguchi, & Lamb, 1996) and evidence for the 
predictive validity of the URICA has produced equally mixed findings (Blanchard et al., 
2003; Henderson, Saules, & Galen, 2004). 
Data Management.  Data were entered continuously throughout the study by RA’s.  
Within one week of data entry the Node data manager reviewed the data entered for missing, 
illogical, out of range, and inconsistent values; accuracy of key variables such as gender, age, 
race, treatment assignment, and therapist, as well as checks within and across fields for 
logical inconsistencies.  The above variables were defined in the study Data Dictionary, 
which was distributed to Node Data Managers at the outset of the study.  Weekly status 
reports were distributed to the research assistants which identified any problems that were 
encountered that needed correction and clarification.    
Participant confidentiality was maintained through a numbered reference system with 
participants names appearing only on the “key”, which was kept by the project coordinator at 
each site.  Additionally, a Federal Certificate of Confidentiality was obtained by each to 
ensure that there were no increased risks to participants beyond that which would be incurred 
through seeking and entering treatment at the participating CTP.   
Variables for Present Study 
Variables abstracted from the original data set or created by modifying the original 
data set measures are as follows: 
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Demographics.  Age; race (Caucasian, African American, Hispanic, Other), years of 
education, marital status (married/cohabitating, all others [e.g., never married/divorced/ 
separated/ widowed]), employment status (full time/part time/student, 
unemployed/disabled/not working outside the home). 
Treatment Condition.  Motivational Enhancement Therapy (MET) or Treatment As 
Usual (TAU). 
Substance Use.  Substance use was measured using the Substance Use Calendar 
(SUC) at four time points; baseline, post intervention, one month post intervention and three 
months post intervention.  A single number, representing average number of days using 
primary substance, was created from the SUC for mean baseline days of primary substance 
use per week.  This continuous variable has values from 0-7.  Primary substance use during 
the study was measured by the SUC and provided 16 sequential weekly data points.  These 
continuous variables are scored 0-7 and represent the number of days using the primary 
substance during each of the 16 weeks post randomization. 
Treatment Retention.  Treatment retention was measured using the Treatment 
Utilization Form (TUF) at the 16 week follow up.  It was defined categorically by using the 
yes or no response to “participant active in treatment at 16 weeks post-randomization” from 
the TUF. 
Treatment Phase.  The data were divided into two discrete time points, or phases, 
because of the possible changes in slope due to the treatment condition.  One Phase consisted 
of baseline through week 4; the second Phase consisted of week 5 through 16.   
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Primary Substance.  Initially identified by a categorical variable on the demographic 
form; cocaine, methamphetamine, alcohol, opiates, marijuana, other, alcohol and drug).  See 
percentages on Table 1. 
Table 1. 
Primary Substance (from Demographic Form) (n = 461) 
 %  
Cocaine 23.2% 
Methamphetamine 3.5% 
Alcohol 28.6% 
Opiates 9.3% 
Marijuana 15.6% 
Other 8.2% 
Alcohol and Drug 11.5% 
 
The initial consideration was to collapse substance use into 3 categories; alcohol only, drug 
only, and drug and alcohol.  After preliminary analyses it was decided that the frequencies of 
these categories were too small for the analyses proposed (see table 2).   
Table 2. 
Primary Substance Used (3 grouping) 
 %  
Primary Alcohol 28.6% 
Primary Drug(s) 56.4% 
Primary Alcohol and Drug(s) 15.0% 
 
Several grouping strategies were assessed and the decision was made to collapse the 
substance use categories into a dichotomous variable; primary alcohol users and primary 
drug users.  The primary alcohol variable contains any alcohol use while the primary drug 
category contains one or more drugs used but no evidence of primary alcohol use.  The 
decision to combine the groups was supported by the literature (Ball et al, 2007) and by the 
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similarities observed for the alcohol only and alcohol and drug groupings (e.g. age, marital 
status, ethnicity, life time # of arrests, lifetime psych # of psych treatments).  These 
similarities were not observed with the drug only group.  The decision was made to combine 
the two groups based on sample size of the primary alcohol and drugs group (15%), existing 
literature and the similarities between the two groupings. Participants self identified primary 
substance was used to create a dichotomous variable with the following values, Alcohol: 
participant reported alcohol to be the primary substance they used; or Drug: participant did 
not report alcohol as the primary substance use, which then categorized the participant as 
primary drug.  From this, the two category primary substance variable was created, those 
with primary alcohol and those with primary drug (with no alcohol). 
Legal status.  Using the demographic form, the legal status of the participants 
(n=461) was assessed.  Participants responded to one of five choices; “mandated or referred 
as alternative to jail” (17.4%), “referred by probation/parole officer” (8%), “referred by other 
federal/state/private agency” (8.2%), “other legal issues involved” (3.7%), and “no known 
legal issues involved” (62.7%).   This information was re-coded into a 3 group categorical 
variable where 62.7% reported no legal involvement, 20% reported some legal involvement 
(“referred by probation/parole officer”; “referred by other federal/state/private agency”; 
“other legal issues involved”) and 17.3% reported3 that they were mandated to treatment.  
These variables showed that in a three group legal variable that only n=19 cases were 
mandated in the primary 'alcohol' group compared to n=61 for 'other drug' group.  Some legal 
involvement is n=30 for 'alcohol' and n=62 for 'other drug'.  No legal involvement is n=152 
for 'alcohol' and n=137 for 'other drug'.  The small numbers of participants in the mandated to 
treatment category for alcohol use (n=19) is small for the research questions and could result 
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in complete separation or quasicomplete separation when more complex statistical analyses 
with covariates are run.  Because of this, it was decided that a dichotomous legal variable 
would be used where there would be “any legal involvement” and “no legal involvement”.  
This variable was obtained by collapsing the legal status variable from the demographic 
form.  The “any legal involvement” group was made by collapsing “mandated or referred as 
alternative to jail”, “referred by probation/parole officer”, “referred by other 
federal/state/private agency”, and “other legal issues involved”.  The “no legal involvement” 
group was made up of the “no known legal issues involved” category. 
Motivation.  Motivation was measured using a composite score created from the 
University of Rhode Island Change Assessment (URICA).  The URICA is a 32 question 
measure of motivation.  The URICA when scored, results in 4 composite scores; 
precontemplation, contemplation, action, maintenance.  A readiness to change score is 
created using the following formula, contemplation + action + maintenance – 
precontemplation = Readiness to Change Score. The Readiness to Change score can range 
from -2 to 14.  There are no agreed up on cut off scores presented in the literature.  While 
several potential algorithms are presented in the literature (Callaghan, Taylor, Moore, 
Jungerman, Andrioni De Biaze Vilela, Budney, 2008) there is no consensus.  As such, a 
mean separation was done to create a low and high motivation category using this sample.  
One algorithm, created by the Addition Technology Transfer Center (ATCC) suggested cut 
off scores for the three stages of change; precontemplation (-2-10.15), contemplation (10.16-
11.80), action/maintenance (11.81 and above).  The mean separation yielded comparable 
results to the ATCC algorithm.  Using the mean separation, a total of 225 participants were 
categorized as low motivation, while 226 were categorized as high motivation.  Using the 
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ATCC algorithm 226 participants were precontemplation and 225 were either contemplation 
or action / maintenance.  Using this procedure, motivation was dichotomized into: Low 
Motivation, those with a Readiness to Change score below -2-10.14; and High Motivation, 
those with Readiness to Change scores 10.15-14. 
Data Analysis Plan 
Demographics and Initial Analyses.  Statistical analyses were performed using 
SPSS v.18.0 (SPSS, Chicago, IL). The data set obtained for this secondary data analysis had 
already been prepared for use (see Ball et al., 2007).  Comparisons of participant 
characteristics between MET and TAU were performed by means of ANOVA and chi-square 
analysis.  ANOVA and chi-square analysis were also conducted to examine differences in 
site characteristics.  Descriptive analyses to describe demographic characteristics (e.g., age, 
race) were calculated. 
Hypotheses.  The hypothesized relationships between intervention group and legal 
status on primary substance use and treatment retention were examined (Hypothesis 1). A 
mixed linear model was fit with Treatment Group, Legal Status, Time, all possible 
interactions and the treatment outcome (dependent measure) of Substance Use was 
examined.  Nonsignificant interactions and main effects, and additional covariates, that did 
not add to the model were removed until the most parsimonious model was arrived at.  
Binary logistic regression was conducted to predict the outcome of treatment retention 
(defined categorically by “participant active in treatment at 16 weeks post-randomization”, 
yes/no) using Treatment Group (MET, TAU) and Legal Status (incentives or no incentives) 
as predictors (Hypothesis1). 
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A relationship was hypothesized for intervention group and primary substance and 
legal status on primary substance use was examined (Hypothesis 2). A mixed linear model 
was fit with Treatment Group, Primary Substance, Legal Status, Time, all possible 
interactions and the treatment outcome (dependent measure) of Substance Use was 
examined.  Nonsignificant interactions and main effects that did not add to the model were 
removed until the most parsimonious model was achieved.   
The hypothesized relationships between intervention group and motivation on 
primary substance use and treatment retention were examined (Hypothesis 3). A mixed linear 
model was fit with Treatment Group, Motivation, Time, all possible interactions and the 
treatment outcome (dependent measure) of Substance Use was examined.  Nonsignificant 
interactions and main effects that did not add to the model, including additional covariates, 
were removed until the most parsimonious model was arrived at.  Binary logistic regression 
was conducted to predict the outcome of treatment retention using Treatment Group and 
Motivation (high/low) as predictors (Hypothesis 3). 
Results 
Data Analysis 
Outliers and Tests of Normality.  Frequency distributions of continuous variables 
that represented substance use were examined for evidence of non-normality and outliers. If 
the data contained outliers and there was a meaningful rationale to remove them (e.g., 
outliers were not expected), they were coded as missing. If by removing outliers the data 
were normal, no further changes were made to the variable.  Variables were re-coded from 
continuous to categorical variables because non-normal variables prevented the use of 
45 
 
ANOVA. Following the re-coding of any non-normal variables, mean scores and frequencies 
were calculated for each variable.  
Initial examination of years of education completed was found to be skewed and 
kurtotic. When one outlier was removed however, the data were normally distributed, 
remaining slightly Kurtotic but below 1.5, with average education being 12.55 years (SD=2).   
The lifetime arrests of participants was non-normally distributed.  A total of 11 were over 3 
SD above the mean and were removed.  After the removal of the 11 extreme data points the 
descriptive statistics were re-run and while the sample was still slightly skewed and kurtotic, 
the values were not above 1.5 on either statistic.  Several of the variables were assessed only 
at baseline and as such, contain the whole (n = 461) sample.  These variables include gender, 
ethnicity, age, employment patter, primary substance used and marital status.  No values 
were missing from these variables.  These variables were normally distributed and within 
expected ranges.   
Substance use was assessed at 4 time points.  From this, a baseline use mean score 
was created and 16 weekly time points.  Weekly data points were created from the SUC 
based on the responses at the 4 time points.  A total of 425 participants provided baseline 
substance use.  Participant attrition was expected as treatment progressed.  Missing data were 
coded as such.  
Demographics: Descriptive statistics for the study participants (N=461) are 
summarized in Table 3.  Age was normally distributed with the average age of participants 
being 34.8 years (SD= 10.21, 18-64 years old). The sample was male (70.9%).  Race was 
evenly distributed between Blacks (42%) and Caucasian (42%), with the remaining 11% 
Hispanic and 5% “Other”.  Participants reported a mean of 12.5 years formal education (SD 
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= 2.00, range 7-20 years) and most were never married or single (81.6%) at the time of study 
participation.  
Table 3. 
Participant Characteristics: MET (n = 216) and TAU (n =245) 
 MET 
% or M (SD) 
TAU 
% or M (SD) 
Total Sample 
% or M (SD) 
Legal Status    
    No legal involvement 63.4% 62.0% 62.7% 
    Legal involvement 36.6% 38.0% 37.3% 
Primary Substance    
     Alcohol 45.4% 42.0% 43.6% 
     Drug(s)  56.6% 58.0% 56.4% 
Age (years) 33.0 (10.5) 35.5 (9.9) 34.8 (10.2) 
Gender    
     Male 69.9% 71.8% 70.9% 
     Female 30.1% 28.2% 29.1% 
Education (years) 12.6 (2.0) 12.5 (2.0) 12.6 (2.0) 
Marital Status    
      Married/cohabitating 20.4% 16.7% 18.4% 
      Single/divorced/separated/widowed 79.6% 83.3% 81.6% 
Ethnicity    
     Caucasian 45.4% 38.8% 41.9% 
     African American 39.4% 44.9% 42.1% 
     Hispanic 10.2% 11.0% 10.6% 
     Other 5.1% 5.0% 5.4% 
Currently awaiting charges or 
sentencing (y) 
13.5% 16.3% 15% 
Employed in the past 30 days (y) 40.3% 38.8% 39.5% 
Total lifetime number of arrests 4.8(5.2) 5.2(5.5) 5.0 (5.4) 
Total number of months incarcerated 
lifetime 
10.4(22.3) 10.0(21.3) 10.2(21.7) 
 
Primary Substance Use Characteristics.  Chi-square tests of the relationship 
between categorical demographic variables and substance use and standard crosstabs were 
used for comparison of continuous variables (see Table 5).  Men and women did not differ in 
patterns of substance use characteristics, χ2 (2,461) = .848, p > .05.  However, a difference 
was found across race/ethnicity groups specifically, between substance used (primary 
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alcohol, primary drug) and identified ethnicity χ2 (3, 461) = 13.21, p < .004, Cramer’s V = 
.17.  Caucasian and African Americans were similar, with between 41% and 51% reporting 
primary alcohol use, where as Hispanics and ‘other’ reported only 24.5% and 36% primary 
alcohol use respectively.  Substance use also varied by marital status χ2 (5, 461) = 22.15, p < 
.001, Cramer’s V = .22.  For alcohol as the primary substance, the percentage of participants 
who were married was 22.9% compared with only 10% of other drug users and 48.3% of 
alcohol users were never married compared with 66.5% of other drug users.   A one-way 
between groups analysis of variance showed a significant difference between primary 
substance used and years of education, F(1,458) = 17.264, p <.001.  Additionally there was a 
significant difference between substance and age F (1,459) = 45.506, p <.001.  A difference 
was found across current employment χ2 (1, 461) = 7.39, p = .007, Cramer’s V = .131.  Of 
the participants who primarily used alcohol, 46.8% had full or part time employment 
compared with 33.8% of primary drug users.  Rates of various substance use characteristics 
are further summarized in Table 4. 
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Table 4. 
Primary Substance Use Characteristics: Primary Alcohol (n = 201) and Primary Drug (no 
alcohol) (n = 260) 
 Primary 
Alcohol 
% or M 
(SD) 
Primary 
Drug (no 
alcohol) 
% or M 
(SD) 
Total 
Sample 
% or M 
(SD) 
p 
Age (years) 38.3 (9.9) 32.1 (9.6) 34.8 (10.2) <.001*** 
Gender     
     Male 71.6% 70.4% 70.9%  
     Female 28.4% 29.6% 29.1% ns 
Education (years) 13.0 (2.1) 12.2 (1.9) 12.6 (2.0) <.001*** 
Marital Status     
      Married/cohabitating 24.9% 13.5% 18.4%  
      Single/divorced/separated/widowed 75.1% 86.5% 81.6% .002** 
Ethnicity     
     Caucasian 39.8% 43.5% 41.9%  
     African American 49.8% 36.2% 42.1%  
     Hispanic 6.0% 14.2% 10.6%  
     Other 4.5% 6.2% 5.4% .004** 
Employment     
     Full or part time past 30 days 46.8% 33.8% 39.5%  
     Unemployed/disability/not working 53.2% 66.2% 60.5% .005** 
     
 
Note. *p <.05. **p <.01, ***p<.001   
Legal Status.  As anticipated, a chi-square test for independence did show a 
significant association between legal status from the demographic form (mandated or 
referred as alternative to jail, referred by probation/parole officer, referred by other 
federal/state/private agency, other legal issues involved, and no known legal issues involved) 
and a dichotomous (yes/no) variable from the ASI  which asked “was the treatment 
admission prompted by the legal system” χ2(4,n=460) = 393.15, p < .001, Cramer’s V = .92.  
A second Chi-square test for independence showed a significant association between legal 
status as a 3 category variable (legally mandated, some legal involvement, no legal 
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involvement) and the dichotomous (yes/no) variable from the ASI  which asked “was the 
treatment admission prompted by the legal system” χ2(2,n=460) = 372.00, p < .001, 
Cramer’s V = .90.  A Chi-square test for independence (with continuity correction) showed a 
significant association between dichotomous legal status created from the demographic form 
(any legal involvement/no known legal involvement) and a dichotomous (yes/no) variable 
from the ASI  which asked “was the treatment admission prompted by the legal system” 
χ2(1,n=460) = 353.63, p < .001, Cramer’s V = .88.  A Pearson product-moment correlation 
coefficient conducted with these two variables shows a strong positive correlation, r = .918, 
n=461, p < .001, with 84% shared variance.  These results suggest that the use of the 
dichotomous legal variable created from the legal status question on the demographic form is 
significantly correlated with the legal status variable from the ASI and encourages the use of 
only one of the legal variables identified in this protocol.  The collapsed variable used was 
the dichotomous variable created from the Demographic Form. 
There was a significant association observed between the dichotomous legal status 
and primary substance used.  A Chi-square test of independence (with continuity correction) 
showed χ2 (1, 460) = 24.51, p < .001, Cramer’s V = .24.  Almost three quarters (71.5%) of 
those participants who had legal involvement identified drugs as their primary substance 
compared with only one quarter (28.5%) of participants who identified alcohol as their 
primary substance.   
A Chi-square test of the relationship between categorical demographic variables and 
legal status and standard crosstabs were used for comparison of continuous variables (see 
Table 5).  A one-way between groups analysis of variance showed a significant difference 
between legal status and years of education, F (1,458) = 10.60, p =.001.  Additionally there 
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was a significant difference between legal status and age F (1,459) = 77.43, p <.001.  
Participants with legal involvement were significantly younger (M = 29.77, SD = 9.15) than 
those entering treatment without legal involvement (M = 37.79, SD = 9.64).  A difference 
was also observed across current employment χ2 (1,461) = 4.36, p = .019, Cramer’s V = 
.029.  Of those who were legally involved, 45.9% had full or part time employment 
compared with 54.1% who did not.  For participants with no legal involvement 35.6% held 
full or part time employment compared with 64.4% who did not.   
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Table 5. 
Participant Legal Characteristics: No Legal Involvement (n =288) and Legal Involvement (n 
= 172) 
 Legal 
Involvement 
% or M 
(SD) 
No Legal 
Involvement 
% or M 
(SD) 
Total 
Sample 
% or M 
(SD) 
p 
Primary Substance Used     
     Primary Alcohol 28.5 52.6 43.6  
    Primary Drug(s)  71.5 47.4 56.4 <.001*** 
Age (years) 29.77 (9.15) 37.79 (9.64) 34.80 
(10.21) 
<.001*** 
Gender     
     Male 73.8 69.2 70.9  
     Female 26.2 30.8 29.1 Ns 
Education (years) 12.20 (1.89) 12.78 (2.00) 12.55 
(2.00) 
.001** 
Marital Status     
      Married/cohabitating 12.8 21.8 18.4  
      
Single/divorced/separated/widowed 
87.2 78.2 81.6 .016* 
Ethnicity     
     Caucasian 46.5 39.1 41.9  
     African American 34.3 46.7 42.1  
     Hispanic 12.8 9.3 10.6  
     Other 6.4 4.8 5.4 Ns 
Employment     
     Full or part time past 30 days 45.9 35.6 39.5  
     Unemployed/disability/not working 54.1 64.4 60.5 .019* 
     
 
Note. *p <.05. **p <.01, ***p<.001   
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Readiness to Change. The URICA Readiness to Change score was computed for 452 
of the participants.  A total of 9 participants had incomplete URICA subscales which did not 
allow for the creation of a Readiness to Change score for these participants and they were 
excluded listwise from analyses using the Readiness to Change score.  An independent 
samples t-test was conducted to compare the Readiness to Change (high, low) scores at 
baseline for the two treatment conditions (MET, TAU).  There were no significant difference 
in scores for MET (M=10.07, SD = 2.01) and TAU (M=10.34, SD=1.80); t (450) = 1.51, 
p=.132.  This shows that there is not a significant difference between the two treatment 
conditions and the Readiness to Change score at the baseline assessment.  
A Chi-square test of independence for Readiness to Change (high, low) and intervention 
assignment (MET, TAU) did not show a significant difference χ2 (1, 451) = 3.37, p = .066.    
Additionally, an analysis of primary substance used did not result in a significant difference, 
χ2 (1, 451) = .660, p = .417.  A significant difference was observed for legal status and 
Readiness to Change score, χ2 (1, 451) = 48.322, p < .001, Cramer’s V = .332.   Participants 
who did not have legal involvement were more likely to have high motivation (62.9%) while 
participants who were legally involved were more likely to have low motivation (71.4%).   
There was also a significant difference present for gender and Readiness to Change score, χ2 
(1, 451) = 10.818, p = .001, Cramer’s V = .160.  Within gender, men were more likely to be 
in low motivation (55%) compared to women (37.4%).  There was also a significant 
difference for age, F (1,459) = 37.51, p <.001, with participants in the high motivation group 
being older.  Further explanation of findings can be seen in Table 6. 
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Table 6. 
Primary Characteristics of Readiness to Change Categories: Low (n =226), High (n = 226) 
 Low 
Motivation 
% or M (SD) 
High 
Motivation 
% or M 
(SD) 
p 
Treatment Condition    
    MET 54.7% 45.3%  
     TAU 45.6% 54.4% ns 
Primary Substance Used    
     Primary Alcohol 47.5% 52.5%  
    Primary Drug(s)  51.8% 48.2% ns  
Legal Status    
    Legal involvement 71.4% 28.6%  
     No legal involvement 37.1% 62.9% <.001*** 
Age (years) 32.0(10.3) 37.7(9.3) <.000*** 
Gender    
     Male 78.2% 63.7%  
     Female 21.8% 36.3% .001** 
Education (years) 12.4(1.8) 12.7(2.2) ns 
Ethnicity    
     Caucasian 52.3% 47.7%  
     African American 47.9% 52.1%  
     Hispanic 50.0% 50.0%  
     Other 100.0% 0% ns 
    
 
Note. *p <.05. **p <.01, ***p<.001   
Replication Analyses.  The first aim of this study was to replicate the findings from 
the primary article which utilized this data set.  To assure the data set was the same and to 
provide sample characteristics the results of the primary retention and substance use 
outcomes by therapy condition and program site were replicated and are presented in table 7. 
The results of the replication of patient and program differences across site are presented in 
table 8.  There were no substantive differences between the results of these analyses and 
those previously conducted by the primary article (Ball et al., 2007).  Some fluctuations were 
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observed, however, the fluctuations were minor and likely due to differences in the statistical 
packages used.   
Table 7. 
Patient and Program Differences across Site (n = 461) 
 Site 1 
% or 
Site 2 
M 
(SD) 
% or 
Site 3 
M 
(SD) 
% or 
Site 4 
M 
(SD) 
% or 
Site 5 
M 
(SD) 
% or 
Total 
M 
(SD) 
% or 
p 
M 
(SD) 
Gender (female) 17.0 26.0 25.0 29.5 48.0 29.1 <.005 
Ethnicity       <.005 
    African Amer. 25.0 31.0 45.0 45.9 64.0 41.9  
    Caucasian 59.0 63.0 40.0 42.6 6.0 42.1  
    Hispanic 13.0 1.0 14.0 3.3 19.0 10.6  
    Other 3.0 5.0 1.0 8.2 11.0 5.4  
Age 35.33 
(9.7) 
39.56 
(9.5) 
29.35 
(9.4) 
34.47 
(11.4) 
35.15 
(9.1) 
34.80 
(10.2) 
<.005 
Years education 11.84 
(2.0) 
13.07 
(2.0) 
12.14 
(1.7) 
12.36 
(1.6) 
13.42 
(2.6) 
12.58 
(2.1) 
<.005 
Marital status       <.005** 
  
Married/cohabitat
ing 
6.0 34.0 9.0 6.6 32.0 18.4  
Widowed/ 
separated 
32.0 27.0 12.0 23.0 21.0 23.0  
  Not married/ 
single 
62.0 39.0 79.0 70.5 47.0 58.6  
Previous 
Treatment 
       
  Alcohol 56.6 41.0 20.0 41.0 39.0 39.3 <.005** 
  Drug 84.8 45.0 53.0 42.6 57.0 57.6 <.005** 
# Psychiatric 
Treatment 
1.95 (3.1) 1.01 (1.6) .77 (2.2) 5.31 
(9.8) 
2.20 
(2.7) 
1.99 
(4.5) 
 
Legal involved        
  Court mandate 12.0 9.0 57.0 55.7 18.0 28.2 <.005** 
 Legal sys referral 13.1 4.0 75.0 54.1 23.0 32.2 <.005** 
 Current probation 
/parole 
27.3 9.0 68.0 39.3 28.0 33.9 <.005** 
 # lifetime arrests 6.89 (7.5) 2.61 (3.7) 5.48 
(7.0) 
7.62 
(8.7) 
7.18 
(8.2) 
5.81 
(7.3) 
<.005** 
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Table 7 (continued) 
       
 # months 
incarcerated 
17.11 
(26.9) 
2.08 (8.4) 10.31 
(12.8) 
12.61 
(23.0) 
9.88 
(23.5) 
10.20 
(21.7) 
<.005** 
Primary 
substance 
       
 Alcohol 9.23 (7.2) 10.36 
(9.1) 
12.07 
(10.7) 
7.47 
(9.0) 
11.58 
(8.9) 
10.44 
(9.2) 
<.005** 
Cocaine 6.92 (7.2) 9.38 (8.8) 5.32 
(8.5) 
7.08 
(8.5) 
7.55 
(8.3) 
7.26 
(8.2) 
<.005** 
opioids 6.90 (7.5) 4.17 (7.1) 2.89 
(6.6) 
2.54 
(5.3) 
3.95 
(6.7) 
4.22 
(6.9) 
<.005** 
marijuana 2.30 (5.2) .25 (1.8) 1.22 
(4.5) 
0.13 
(0.5) 
1.03 
(3.9) 
1.06 
(3.8) 
<.005** 
Years substance 
Use 
3.57 (6.4) 3.10 (7.2) 7.08 
(10.1) 
1.95 
(4.1) 
4.26 
(8.8) 
4.16 
(8.0) 
<.005** 
 Alcohol 13.21 
(9.8) 
15.22 
(10.4) 
9.74 
(9.3) 
15.70 
(10.6) 
9.60 
(8.4) 
12.44 
(10.0) 
<.005** 
Cocaine 8.06 (7.0) 6.25 (7.4) 3.76 
(6.3) 
6.44 
(8.4) 
4.01 
(5.3) 
5.64 
(7.0) 
<.005** 
Opioid 1.32 (2.8) 0.10 (0.8) 0.80 
(2.2) 
1.77 
(5.3) 
1.03 
(3.8) 
0.94 
(3.1) 
<.005** 
Marijuana 9.27 (9.0) 8.18 (8.6) 7.51 
(7.4) 
8.03 
(7.3) 
6.06 
(7.6) 
7.79 
(8.1) 
.079 
 
Note. *p <.05. **p <.01, ***p<.001   
 
 
 
 
 
 
 
 
 
 
56 
 
Table 8. 
Outcome by Site and Therapy Condition (n = 461) 
 MET  
M (SD) 
TAU 
M (SD) 
Therapy 
Condition 
Program Site Therapy X 
Site 
Days enrolled 
in Tx Site 1 
71.33 (42.97) 74.61 (40.90)    
Days enrolled 
in Tx Site 2 
65.83 (38.91) 60.55 (30.36)    
Days enrolled 
in Tx Site 3 
87.09 (44.97) 96.57 (38.35)    
Days enrolled 
in Tx Site 4 
74.63 (38.09) 63.34 (44.11)    
Days enrolled 
in Tx Site 5 
58.92 (44.70) 52.88 (42.89)    
Days enrolled 
in TX  
Total 
72.23 (43.14) 69.23 (42.12) F (1.376) = 
.217, P=.642 
F (4.376) = 
9.556, P 
<.001*** 
F (4.376) = 
.781, P = 
.583 
% enrolled at 
follow up 
Site 1 
.33 (.48) .41 (.50)    
% enrolled at 
follow up 
Site 2 
.28 (46) .19 (.40)    
% enrolled at 
follow up 
Site 3 
.74 (.44) .85 (.35)    
% enrolled at 
follow up 
Site 4 
.43 (.50) .41 (.50)    
% enrolled at 
follow up 
Site 5 
.43 (.50) .43 (.50)    
% enrolled at 
follow up 
Total 
.47 (.50) .46 (.50) F (1.375) = 
.108, P=.743 
F (4.375) = 
.16.92, 
P<.001*** 
F (4.375) = 
.606, 
P=.659 
 
Note. *p <.05, **p <.01, ***p<.001   
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Data Checking 
The first aim on the current study was to replicate findings reported by Ball et al. 
(2007) in the primary outcome paper.  Previous research showed that with this sample there 
would be a reduction in primary substance use during the experimental phase of treatment 
which would be observed for both intervention conditions (MET, TAU).  A mixed linear 
model tested the effectiveness of the interventions (MET vs. TAU) by substance use through 
intervention completion (Baseline through Week 4) and the effectiveness of the interventions 
(MET vs. TAU) post-intervention (Week 4 through week 16).   
A Mixed Linear Model was run with the following variables; Treatment Group 
(MET, TAU), Phase (baseline through week 4, week 5 through week 16), and Time (baseline 
followed by 16 weekly data points).  Each participants unique identification number was 
used to anchor their data.  The study involved an intervention arm (MET or TAU for week 1-
4) and substance abuse treatment at participating programs throughout the 16 week period of 
assessment.  Since the first 4 weeks provided a different level of care from that offered in 
weeks 5-16, it was deemed inappropriate to force a single linear estimate through all 17 data 
points (baseline and 16 weeks thereafter).  Specifically the original study posited that 
changes in slope should accompany the transition between the intervention treatment phase 
and post intervention.   Instead, a repeated covariance type of compound symmetry was 
chosen thereby allowing for the split-plot design, necessary for the Phase variable.   
The model using Treatment Group, Phase, and Time was run with all possible two, and three-
way interactions; results are summarized in Table 9.   
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Table 9. 
Data Checking: Treatment Group X Phase X Time 
 
 Model 1 (without additional covariates) 
Variable F P 
Phase 165.442 .000*** 
Time 228.595 .000*** 
Treatment Group 1.097 .295 
Phase X Time 231.590 .000*** 
Phase X Treatment Group 9.584 .002* 
Time X Treatment Group 6.329 .012* 
Phase X Time X 
Treatment Group 
8.333 .004** 
 
Note. *p <.05, **p <.01, ***p<.001   
As reported by Ball et al. (2007) the present analyses found a significant main effect 
for Phase, F (1,5170.002) = 165.442, p < .001, and Time, F (1,5242.150) = 228.595, p < 
.001.  Significant two-way interactions were observed for Treatment Group X Phase, F 
(1,5149.870) = 9.584, p = .002, Treatment Group X Time, F (1,5210.135) = 6.329, p = .012, 
and Phase X Time, F (1,5227.472) = 231.590, p < .001. 
The present study also replicated the significant three way interaction (see Figure 4) 
found in Ball et al. (2007) between Treatment Group X Phase X Time, F(1, 5197.615) = 
8.333, p = .004.   As shown in Figure 4, participants randomized to either MET and TAU 
interventions significantly reduced their substance use during the 4-week intervention phase.  
However, participants in the MET intervention maintained these improvements over the 
subsequent 12 week post intervention period, while TAU participants showed an increase in 
substance use during the post intervention period.  
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Week = baseline through 16 weeks; Days per week substance use = days per use of primary 
substance during week each week that was assessed; MET = motivational enhancement 
therapy; TAU = treatment as usual. 
Figure 4.  Data Checking: Three Way Interaction for Treatment Group X Phase X Time 
Hypothesis One 
To test Hypothesis 1, a mixed linear model was fit with the following predictor 
variables; Treatment Group (MET, TAU), legal status at treatment entry (no legal 
involvement, legal involvement) and Time (mean weekly use prior to entry into treatment 
and 16 weekly data points).  The model tested Treatment Group, Time and Legal Status and 
all interactions terms: Treatment Group, Time, Legal Status, Treatment Group X Time, 
Treatment Group X Legal Status, Time X Legal Status and Treatment Group X Time X 
Legal Status.   Eight variables were added to the model as additional covariates.  The eight 
covariates run were; gender, age, years of education, race (White, Minority), currently 
awaiting charges or sentencing (y/n), employed past 30 days (y/n), total number of  lifetime 
arrests, total lifetime number of months incarcerated.  The findings from this model with 
these additional variables are presented in Table 10 (Model 1).  Then, to see if these 
60 
 
experimental effects remained significant, the model was rerun without the additional 
covariates.  None of the additional covariates contributed significantly to model 1 and 
therefore, they were not retained.  The full model without the additional covariates was 
retained and is shown in table 10 (Model 2).   The following were found to be nonsignificant 
and were removed to create the most parsimonious model, Time X Treatment Group X Legal 
Status, F(1,5164.687) = .011, p =.917, Treatment Group X Legal Status F(1,356.439) = 
2.253, p = .134, Time X Treatment Group, F(1,5163.010) = .186, p = .667, and Treatment 
Group, F(1,356.664) = .061, p = .805. 
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Table 10. 
 
Hypothesis 1: Mixed Linear Model With and Without Additional Covariates 
 Model 1 (with 
additional 
covariates) 
Model 2 (without 
additional 
covariates) 
Model 3(final 
model) 
Variable F p F p F  p 
Treatment group .828 .363 1.164 .281   
Time 79.837 .000*** 81.860 .000*** 143.825 .000*** 
Legal Status 5.599 .018** 7.887 .005** 6.095 .014* 
Treatment Group X Time .039 .843 .119 .731   
Treatment Group X Legal 
Status 
1.494 .222 2.141 .144   
Time X Legal Status 33.470 .000*** 33.871 .000*** 61.490 .000*** 
Treatment Group X Time 
X Legal Status 
.000 .992 .011 .917   
Gender (M/F) .403 .526     
Age .002 .963     
Years of Education .039 .843     
Race (W/M) .053 .818     
Currently waiting 
Charges or Sentencing 
(Y/N) 
.043 .837     
Employed Past 30 Days 
(Y/N) 
.883 .348     
Total # of Lifetime 
Arrests 
1.128 .289     
Total # of Months 
Incarcerated 
.638 .425     
Readiness to Change 
(mean separated) 
.089 .766     
 
Note. *p <.05, **p <.01, ***p<.001   
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The significant main effects for the most parsimonious model (Model 3) included 
Time,  F(1,5171.655) = 143.825, p < .001, Legal Status F(1,440.844) = 6.095, p = .014, and 
as shown in Figure 5, a significant 2 way interaction for Time X Legal Status F(1,5168.642) 
= 61.490, p < .001.  As seen in Figure 6, participants entering treatment without legal 
incentives had similar reductions in substance use regardless of intervention group 
assignment (MET or TAU).  In contrast, participants in both interventions conditions with no 
legal incentives showed little or no reductions in substance use.   
 
Legal = any legal involvement; No Legal = No legal involvement 
Figure 5.  Hypothesis 1: Two-way Interaction for Time X Legal Status (Model 3) 
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MET-L = motivational enhancement therapy with legal involvement; MET-NL = 
motivational enhancement therapy with no legal involvement; TAU-L = treatment as usual 
with legal involvement; TAU-NL = treatment as usual with no legal involvement. 
Figure 6.  Hypothesis 1: Days Using Primary Substance per Week Separated by Treatment 
Group and Legal Status (Model 2) 
A logistic regression was performed to assess the effects of Treatment Group and 
Legal Status on treatment retention at study completion.  The full model was significant, χ2 
(2,461) = 8.242, p = .016, indicating that the model was able to distinguish between 
participants who did and did not stay involved in treatment through study completion.  As 
seen in Table 11, only Legal Status made a significant contribution to the model χ2 (1,461) = 
7.889, p = .005.   The strongest predictor of remaining in treatment was legal involvement, 
recording an odds ratio of 1.873.  This indicates that participants with legal incentives are 
almost twice to still be in treatment at 16 weeks post-enrollment compared to participants 
without such incentives. This finding mirrors previous findings and shows that Treatment 
Group was not significant for changing treatment retention, while Legal Status resulted in 
significant differences in treatment retention from baseline to treatment completion. 
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Table 11. 
Logistic Regression Predicting the Likelihood of Being Active in Treatment at Study 
Completion 
 β S.E. Wald χ2 df  p Odds 
Ratio 
Lower Upper 
Treatment 
Group 
.019 .207 .009 1 .926 1.019 .680 1.529 
Legal 
Status 
.627 .223 7.889 1 .005** 1.873 1.209 2.901 
Constant .658 .158 17.326  .000 1.931   
 
Note. *p <.05, **p <.01, ***p<.001   
Taken together, Hypothesis one was not supported by study findings as participants 
with legal involvement, regardless of intervention conditions, generally reported greater 
reductions in substance use over the course of treatment than those without legal incentives.   
Hypothesis Two  
To test Hypothesis Two, a Mixed Linear Model  was fit with the following predictor 
variables; Treatment Group (MET, TAU), Legal Status at treatment entry (no legal 
involvement, legal involvement), Primary Substance (alcohol, drug [no alcohol]) and Time 
(mean weekly use prior to entry into treatment and 16 weekly data points).  The model was 
fit to test Treatment Group, Legal Status, Primary Substance, Time and all interactions terms: 
Treatment Group, Primary Substance, Legal Status, Time, Treatment Group X Primary 
Substance,  Treatment Group X Time, Treatment Group X Legal Status, Primary Substance 
X Time, Primary Substance X Legal Status, Time X Legal Status, Treatment Group X 
Primary Substance X Time, Treatment Group X Primary Substance X Legal Status, 
Treatment Group X Time X Legal Status, Primary Substance X Time X Legal Status and 
Treatment Group X Primary Substance X Time X Legal Status. 
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  None of the additional covariates added to Hypothesis 1 contributed significantly to 
this model and therefore, they were not retained.  The results of this model are presented in 
Table 12.    
A significant main effect was seen for Time, F (1,5148.617) = 23.244, p < .001.  
Significant two-way interactions were seen for Treatment Group X Time F(1,5130.795) = 
5.235, p = .022, and Time X Legal Status, F(1,5140.162) = 11.860, p = .001.  Significant 
three-way interactions were present for Treatment Group X Primary Substance X Time, 
F(1,5145.783) = 6.377, p = .012, and Treatment Group X Time X Legal Status, 
F(1,5127.103) = 6.722, p = .010.   
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Table 12. 
Hypothesis 2: Final Model Retained for Mixed Linear Model of Treatment Group, Primary 
Substance, Time, Legal Status and All Interactions 
Variable  F p 
Treatment Group 1.108 .293 
Primary Substance .263 .608 
Legal Status 1.972 .161 
Time 23.244 .000*** 
Treatment Group X Primary Substance .298 .585 
Treatment Group X Time 5.235 .022* 
Treatment Group X Legal Status .986 .321 
Primary Substance X Time .109 .741 
Primary Substance X Legal Status .079 .779 
Time X Legal Status 11.860 .001** 
Treatment Group X Primary Substance X Time 6.377 .012* 
Treatment Group X Primary Substance X Legal 
Status 
.006 .938 
Treatment Group X Time X Legal Status 6.722 .010* 
Primary Substance X Time X Legal Status .010 .919 
Treatment Group X Primary Substance X Time X 
Legal Status 
11.231 .001** 
 
Note. *p <.05, **p <.01, ***p<.001   
In addition, the four way interaction for Treatment Group X Primary Substance X 
Time X Legal Status was significant, F(1,5152.083) = 11.231, p = .001 and is shown in 
Figure 7.  To more clearly describe these results, the three-way interaction for Treatment 
Group X Primary Substance X Time is shown for participants with and without legal 
incentives in Figures 8 and 9.  Entering treatment without legal incentives across both 
intervention conditions, shown in Figure 8, resulted in similar slow decreases in substance 
use through treatment except for those in the MET condition using drugs.  Those individuals 
actually showed a slow increase from baseline substance use.  In contrast, as shown in Figure 
9, participants across both treatment conditions with legal incentives showed a more 
pronounced decreases in substance use.  The one exception to this pronounced decrease was 
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for participants in the MET condition with a primary substance of alcohol, these participants 
showed a more modest decrease across treatment comparable to what was seen for 
participants without legal incentives. 
Taken together, Hypothesis Two was not supported by study findings as participants 
with legal involvement and alcohol use in the MET intervention showed only modest 
reductions in substance use.  Overall, regardless of treatment condition or primary substance 
used, those with legal involvement generally reported greater reductions in substance use 
over the course of treatment than those without legal incentives.   
 
 
 
 
 
 
 
 
68 
 
 
MET-A-L = motivational enhancement therapy with alcohol primary and legal involvement; 
MET-A-NL = motivational enhancement therapy with alcohol primary and  no legal 
involvement; MET-D-L = motivational enhancement therapy with drug primary and legal 
involvement; MET-D-NL = motivational enhancement therapy with drug  primary and  no 
legal involvement; TAU-A-L = treatment as usual with alcohol primary and legal 
involvement; TAU-A-NL = treatment as usual with alcohol primary and no legal 
involvement; TAU-D-L = treatment as usual with drug primary and legal involvement; TAU-
D-NL = treatment as usual with drug primary and no legal involvement . 
Figure 7.  Hypothesis 2:  Four-way Interaction of Treatment Group X Legal Status X 
Primary Substance X Time  
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MET-A-NL = motivational enhancement therapy with alcohol primary and no legal 
involvement; MET-D-NL = motivational enhancement therapy with drug primary and no 
legal involvement; TAU-A-NL = treatment as usual with alcohol primary and no legal 
involvement; TAU-D-NL = treatment as usual with drug primary and no legal involvement. 
Figure 8.  Hypothesis 2: Three-way Interaction of Treatment Group X Primary Substance X 
Time for Participants Without Legal Involvement  
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MET-A-L = motivational enhancement therapy with alcohol primary and legal involvement; 
MET-D-L = motivational enhancement therapy with drug primary and legal involvement; 
TAU-A-L = treatment as usual with alcohol primary and legal involvement; TAU-D-L = 
treatment as usual with drug primary and legal involvement. 
Figure 9. Hypothesis 2: Three-way Interaction of Treatment Group X Primary Substance X 
Time for Participants With Legal Involvement 
 
Hypothesis Three 
 To test Hypothesis Three, a Mixed Linear Model was fit with the following predictor 
variables; Treatment Group (MET, TAU), Motivation at treatment entry (low, high), and 
Time (mean weekly use prior to entry into treatment and 16 weekly data points). The model 
was run with Treatment Group, Time, Motivation and all interactions terms: Treatment 
Group, Time, Motivation, Treatment Group X Time, Treatment Group X Motivation, Time 
X Motivation and Treatment Group X Time X Motivation.    
None of the additional covariates added contributed significantly to this model and therefore, 
were not retained.  The results of this model are presented in Table 13.    
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After the removal of nonsignificant terms a significant main effect was seen for Time,  
F(1,5153.926) = 86.161, p < .001.  A significant three way interaction for was seen for Time 
X Treatment Group X Motivation F(1,5330.429) = 5.715, p = .017.  As seen in Figure 10, all 
participants showed a pattern of reducing substance use irrespective of treatment group or 
motivation.  Participants in the MET intervention group with high motivation showed the 
least change in substance use across treatment.   
Table 13. 
Hypothesis 3: Final Model Retained for Mixed Linear Model of Treatment Group, Time, 
Motivation and All Interactions. 
Variable F p 
Treatment group 23.104 .411 
Time .676 .000*** 
Motivation .035 .851 
Treatment Group X Time 1.123 .289 
Treatment Group X Motivation .012 .913 
Time X Motivation .932 .335 
Treatment Group X Time X Motivation 3.963 .047* 
 
Note. *p <.05, **p <.01, ***p<.001   
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MET-High = motivational enhancement therapy with high motivation at baseline; MET-Low 
= motivational enhancement therapy with low motivation at baseline; TAU-High = treatment 
as usual with high motivation at baseline; TAU-Low = treatment as usual with low 
motivation at baseline. 
Figure 10. Hypothesis 3: Three-way Interaction of Time X Treatment Group X Motivation 
Logistic regression was performed to assess the effects of Treatment Group and 
Motivation on treatment retention at study completion.  As seen in Table 14, the full model 
was nonsignificant, χ2(2,451) = .658, p = .720, indicating that retention of participants at 
treatment completion could not be predicted by treatment group or motivation.    
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Table 14. 
Hypothesis 3: Logistic Regression for Predicting the likelihood of Being Active in Treatment 
at Study Completion 
 β S.E. Wald χ2 df  p Odds 
Ratio 
Lower Upper 
Treatment 
Group 
.30 .208 .021 1 .884 1.03 .685 1.551 
Motivation -.163 .208 .610 1 .435 .85 .565 1.278 
Constant .951 .183 26.864  .000 2.588   
 
Note. *p <.05, **p <.01, ***p<.001   
Taken together, Hypothesis Three was not supported by study findings as participants 
with low motivation, regardless of intervention condition, generally reported similar 
reductions in substance use over the course of treatment to those with high motivation.  
Motivation at baseline and treatment group were also unable to predict participation in 
treatment at study completion. 
Exploratory Analysis 
While replicating the analyses and outcomes obtained in the original study by Ball 
and colleagues (2007) it became clear that time was not a linear variable.  Instead, there 
appeared to be 2 phases: intervention phase (experimental [weeks 0-4]); followed by post-
intervention phase (retention [weeks 5-16]).  This finding prompted a reanalysis of the data, 
adding phase as an additional covariate. 
An exploratory analysis was run with the most parsimonious model using the 
variables Treatment Group, Phase, Time and Legal Status and all possible two, three and 
four-way interactions.  As shown in Table 15, a significant main effect was observed for 
Treatment Group, F(1,685.30) = 5.849, p = .016, Phase , F(1,5177.957) = 68.629, p < .001, 
Time , F(1,5259.41) = 106.888, p < .001, and Legal Status, F(1,696.123) = 7.123, p = .008.  
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Significant two-way interactions were seen for Treatment Group X Phase , F(1,5135.89) = 
4.305, p = .038, Treatment Group X Time, F(1,5191.01) = 15.812, p < .001, Treatment 
Group X Legal Status, F(1,686.70) = 5.097, p = .024, and Phase X Time, F(1,5243.77) = 
93.098, p < .001.  Significant three-way interactions were seen for Treatment Group X Phase 
X Time, F(1,5179.21) = 15.130, p < .001, and Treatment Group X Time X Legal Status, 
F(1,5199.99) = 9.956, p = .002. 
In addition, the four way interaction for Treatment Group X Phase X Time X Legal 
Status was significant, F(1,5187.74) = 7.263, p = .007 and is shown in Figure 11.  To better 
understand this interaction, the two graphs (Figures 12 & 13) represent the three way 
interaction between Treatment X Time X Phase separated by the fourth variable, Legal 
Status.  For those participants with legal incentives we see an initial difference in their 
response to the intervention, however following the intervention both groups showed similar 
reductions in substance use (See Figure 12).  Entering treatment without legal incentives had 
similar reductions in substance use during the intervention phase regardless of group 
assignments, however participants in the MET condition showed an initial increase in 
substance use immediately post intervention.  This initial increase in substance use post-
intervention was also seen for TAU but in a gradual increase over the full 12 weeks post 
intervention (See Figure 13).   
 
 
 
 
 
 
75 
 
Table 15. 
Exploratory Analysis: Final Model Retained for Mixed Linear Model of Treatment Group, 
Phase, Time, Legal Status and All Interactions 
Variable F P 
Treatment Group 5.849 .016* 
Phase 68.629 .000*** 
Time 106.888 .000*** 
Legal Status 7.123 .008** 
Treatment Group X Phase 4.305 .038* 
Treatment Group X Time 15.812 .000*** 
Treatment Group X Legal Status 5.097 .024* 
Phase X Time 93.098 .000*** 
Phase X Legal Status .137 .712 
Time X Legal Status 1.498 .221 
Treatment Group X Phase X Time 15.130 .000*** 
Treatment Group X Phase X Legal Status .039 .844 
Treatment Group X Time X Legal Status 9.657 .002** 
Phase X Time X Legal Status .072 .788 
Treatment Group X Phase X Time X Legal Status 7.263 .007** 
 
Note. *p <.05, **p <.01, ***p<.001   
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MET-L = motivational enhancement therapy with legal involvement; MET-NL = 
motivational enhancement therapy with no legal involvement; TAU-L = treatment as usual 
with legal involvement; TAU-NL = treatment as usual with no legal involvement . 
Figure 11.  Exploratory Analyses: Four-Way Interaction of Treatment Group X Phase X 
Time X Legal Status   
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MET-L = motivational enhancement therapy with legal involvement; TAU-L = treatment as 
usual with legal involvement. 
Figure 12.  Exploratory Analysis: Three-Way Interaction of Treatment X Time X Phase 
Separated by Legal involvement 
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MET-NL = motivational enhancement therapy with no legal involvement; TAU-NL = 
treatment as usual with no legal involvement . 
Figure 13.  Exploratory Analysis: Three-Way Interaction of Treatment X Time X Phase 
Separated by No Legal Involvement 
Given the complexity of a four-way interaction and to further parse out the effect of 
Phase, A mixed linear model was conducted with only the intervention phase.   This model 
was fit to test the following variables; Treatment Group (MET, TAU), and Time (mean 
weekly use prior to entry into treatment, week 1, week 2, week 3, week 4) and legal status at 
treatment entry (no legal involvement, legal involvement).  The model tested the Treatment 
Group, Time and Legal Status variables.  All interactions terms were assessed for the 
intervention phase of treatment: Treatment Group, Time, Legal Status, Treatment Group X 
Time, Treatment Group X Legal Status, Time X Legal Status and Treatment Group X Time 
X Legal Status.   None of the additional covariates added to previous models contributed 
significantly to the model and therefore, they were not retained.  To create the most 
parsimonious model, the analysis was run with the three primary variables, Treatment Group, 
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Legal Status, Time and all potential interactions.   As shown in Table 16, Main effects for the 
most parsimonious full model included Treatment Group F(1,679.12) = 4.544, p = .033, 
Time F(1,1423.85) = 73.358, p < .001, and Legal Status F(1,690.09) = 5.194, p = .023, as 
well as a significant 2 way interaction for Treatment Group X Time F(1,1396.91) = 10.628, p 
= .001.   
Table 16. 
Exploratory Analysis: Final Model Retained for Mixed Linear Model of Treatment Group X 
Time X Legal Status and All Interactions for the Intervention Phase. 
 Model without covariates 
Variable F P 
Treatment group 4.544 .033* 
Time 73.358 .000*** 
Legal Status 5.194 .023* 
Treatment Group X Time 10.628 .001** 
Treatment Group X Legal Status 3.512 .061 
Time X Legal Status .707 .400 
Treatment Group X Time X Legal Status 6.248 .013* 
 
Note. *p <.05, **p <.01, ***p<.001   
In addition, a significant three-way interaction for Treatment Group X Time X Legal 
Status was found, F(1,1400.70) = 6.248, p = .013, and is shown in Figure 14.  Participants 
entering treatment without legal incentives had similar reductions in substance use regardless 
of intervention group assignment (MET or TAU).  In contrast, participants with legal 
incentives responded differently based on intervention group assignment.  Those receiving 
MET showed a more modest decrease in substance use over time as opposed to those in the 
TAU intervention group.  Participants with legal involvement generally reported greater 
substance use over the intervention period than those without legal involvement. 
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MET-L = motivational enhancement therapy with legal involvement; MET-NL = 
motivational enhancement therapy with no legal involvement; TAU-L = treatment as usual 
with legal involvement; ; TAU-NL = treatment as usual with no legal involvement . 
Figure 14. Exploratory Analysis:  Three-Way Interaction of Treatment Group X Time X 
Legal Status 
A similar mixed linear analysis was run for the variables, Treatment Group, Time, 
Legal Status  and all interaction terms for the 12 week post intervention phase (weeks 5-16) 
of the study: Treatment Group, Time, Legal Status, Treatment Group X Time, Treatment 
Group X Legal Status, Time X Legal Status and Treatment Group X Time X Legal Status.  
As with previous models, potential covariates were first tested in the model.  When found to 
be nonsignificant, the covariates were eliminated from the model (Model 1).  The most 
parsimonious model is presented below (Model 2) and is shown in Table 17.  
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Table 17. 
Exploratory Analysis: Final Model Retained for Mixed Linear Model of Post-Intervention 
Phase for Treatment Group, Time, Legal Status and All Interactions. 
 Model 1 Model 2 
Variable F p F p 
Treatment Group .250 .671   
Time 2.971 .085 5.536 .019* 
Legal Status 1.991 .159 .815 .367 
Treatment Group X Time .000 .993   
Treatment Group X Legal Status 1.228 .268   
Time X Legal Status 21.511 .000*** 25.817 .000*** 
Treatment Group X Time X Legal 
Status 
1.752 .186   
 
Note. *p <.05, **p <.01, ***p<.001   
A significant main effect was observed for Time F(1,3337.16) = 5.536, p = .019.  A 
significant 2-way interaction was found between Time X Legal Status, F(1,3334.895) = 
25.817, p < .001, and is shown Figure 15.  During the post-intervention period, as shown in 
Figure 16, participants entering treatment with legal incentives continued to show 
comparable rates of decline in substance use regardless of intervention group assignment.   In 
contrast, participants without legal incentives showed a different response with an increase in 
substance use over the 12-week post intervention period. 
Overall, the data support the role of  legal incentive, irrespective of treatment group, 
for sustained reductions in substance use over the post-intervention period. 
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Legal = any legal involvement; No Legal = no legal involvement 
Figure 15.  Exploratory Analysis: Two-way Interaction of Time X Legal Status   
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MET-L = motivational enhancement therapy with legal involvement; MET-NL = 
motivational enhancement therapy with no legal involvement; TAU-L = treatment as usual 
with legal involvement; TAU-NL = treatment as usual with no legal involvement . 
 
Figure 16. Exploratory Analysis: Days Using Primary Substance per Week Separated by 
Treatment Group and Legal Status during the Post-Intervention Phase 
Discussion 
The present study examined whether individuals with and without legal incentives to 
enter substance abuse treatment differed in their response to MET, a brief motivational 
intervention to improve engagement and early retention in substance abuse treatment.  Using 
data from a multisite clinical trial of MET (CTN-0004), the present study first compared 
participants with and without legal incentives to enter treatment on a variety of baseline 
demographic and substance use characteristics.  Second, mixed linear models and logistic 
regression were used to determine whether type of intervention and legal status interacted in 
predicting outcomes of substance use (greater reduction in days per week of substance use) 
and treatment retention (higher rates of treatment retention at 16 weeks).  Third, Readiness to 
change scores (high/low) were compared for participants with and without  legal incentives 
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to enter treatment.  In addition, the study examined whether level of motivation (readiness to 
change) at study enrollment predicted treatment across the two Treatment and Legal Status 
groups.  
Summary of Findings 
When participants randomized to either MET or TAU are further subdivided into 
those with and without legal incentives to enter substance abuse treatment, it was 
hypothesized that those in the MET with legal incentives group will have the most positive 
treatment outcomes (greater reduction in days per week of substance use; higher rates of 
treatment retention at 16 weeks) over time relative to the other three participant subgroups.   
The hypothesis that when participants randomized to either MET or TAU are further 
subdivided into those with and without legal incentives to enter substance abuse treatment, 
that those in the MET with legal incentives group will have the most positive treatment 
outcomes over time relative to the other three participant subgroups was not supported by the 
data.  Similarly, treatment retention rates were higher for participants with legal incentives 
regardless of intervention group assignment.  Given variability across groups in baseline 
rates of primary substance use, additional analyses, controlling for baseline use, were 
performed and in all cases interactions remained statistically significant.  Thus, the observed 
findings could not be explained by the variability in baseline rates of primary substance use. 
While findings confirm the positive relationship between legal incentives to enter treatment 
and measures of treatment outcome, they do not support motivational interventions further 
strengthening this association. 
The hypothesis that when participants randomized to either MET or TAU are further 
subdivided into those with primary alcohol or primary drug and with and without legal 
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incentives to enter substance abuse treatment, those in the MET intervention presenting with 
primary alcohol problems and legal incentives will have the most positive treatment 
outcomes over time relative to the other participant subgroups was not supported.  
Reductions in primary substance use were generally uniform across all participants with a 
legal incentive to enter treatment, but were weakest in the MET with primary alcohol use 
group.  Participants in the MET group with primary drug use and no legal incentive to enter 
treatment actually showed an increase in substance use over the 16 week study period.  Once 
again these results suggest that legal status and not treatment intervention most impacts 
substance use. 
The hypothesis that participants in the MET intervention with low baseline 
motivation to change would show greater reductions in substance use and higher treatment 
retention than participants in the other 3 groups was also not supported. Rather, baseline 
motivation, as measured by the URICA Readiness to Change score, was not associated with 
either measure of treatment outcome.   
Discussion of Findings 
Legal Status.  The present study found participants with legal incentives to enter 
treatment had a more positive outcome than participants without legal incentives for care.  
This is consistent with much of the literature, that is, legal incentives have been associated 
with better treatment retention (Brocato, 2004; Broome et al., 1999; Simpson & Joe, 2004; 
Simpson et al., 1997) and lower rates of substance use (Howard & McCaughrin,1996).  Not 
all studies have found such relationships, however, several studies have found no change in 
substance use (Brecht, Anglin, and Wang, 1993; Hser, Anglin, and Liu, 1991) and lower 
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retention rates (Grichting, Uchtenhagen, and Rehm, 2002; Howard & McCaughrin, 1996) for 
participants with legal incentives prompting further study. 
Some of the variability across studies may stem from how legal encouragement to 
enter treatment is defined and measured. Defining “legal incentive to enter treatment” was 
challenging.  The present study defined it as being mandated or referred as alternative to jail, 
referred by probation/parole officer, referred by other federal, state, private agency or other 
legal issues involved.  Using this definition we found that approximately one third (37.3%) of 
participants were categorized as having legal incentive to enter treatment.  These findings 
were consistent with previous research which showed that between 34% (Niv, Hamilton, 
Hser, 2009) and 42% (Craddock, Rounds-Bryant, Flynn, & Hubbard, 1997) of the clients 
enrolled in publicly funded outpatient drug abuse treatment programs are referred by the 
criminal justice system. Further, the variable was highly correlated with other measures of 
legal involvement from the Addiction Severity Index including an 84% correlation with “was 
the treatment admission prompted by the legal system” (y/n).  Demographically, participants 
with legal incentives were generally younger, less likely to be employed and reported less 
education than those without legal incentives.  Additionally, a significantly higher proportion 
of participants with legal involvement were primary drug users (71.5%).  While it is likely 
that this is a result of the illicit nature of drug use, the legal status variables did not specify 
the event or events that initiated contact with the legal system (except that they were criminal 
and not civil).    
Motivation for substance abuse treatment is a dynamic construct with a complex 
myriad of psychosocial problems (Joe, Simpson, & Broome, 1998) and the absence of legal 
motivation does not preclude an individual from having other extrinsic motivations (e.g. job, 
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family).  Variability across previous studies may come from the fact that when one measures 
“legal incentive to enter treatment”, it is often used as a proxy for extrinsic motivation to 
enter treatment.  Further, this is often used as an absolute measure of patient motivation.  
That is, based solely on a person’s legal status, he/she may be categorized as intrinsically or 
extrinsically motivated to enter treatment.  In this scenario, if a person has a legal reason to 
seek substance abuse treatment, it is then assumed that he/she cannot be internally self-
motivated to enter care.   Clearly a variety of factors can contribute to a person’s decision to 
enter substance abuse treatment.  Marlow and colleagues (1996) identified four dimensions 
of the pressure to enter treatment; the external or internal nature of pressure, the negative or 
positive quality of the pressure, whether pressure is coercive or noncoercive and the 
psychosocial life domain from which the pressure emanates.  Additionally these factors can 
come from a variety of sources, such as family members, friends, employers, the legal 
system, and/or health care providers (Marlow et al., 1996).  The belief that someone with 
legal pressure to seek treatment enters care primarily because of such external factors while 
oversimplified, has guided many segments of the addiction treatment community.  The 
majority of people coming to treatment have some external factors likely to be motivating 
them into treatment.  Legal incentive is one that can more easily be measured and tied to 
clearer consequences than other forms of external motivation. 
Some studies find legally pressured clients do better in substance abuse treatment 
than voluntary clients (Kelly, Finney & Moos, 2005) while others report the opposite (Kelley 
et al., 2005).  The present study hypothesized that if legal incentives to enter treatment create 
a state of high extrinsic motivation, patients in this group may benefit more from an 
intervention designed to focus specifically on stages of change and guiding a person toward 
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greater self-motivation (internal) to change behavior.  This was not the case as rates of 
substance use were comparable for MET and TAU.  
According to Ryan et al. (1995), legal status can be interpreted as an internal or 
external motivation based on the perception of these events by the individual as either being 
controlling or informative.  Events perceived to be controlling will be attributed to external 
forces whereas informative events will be interpreted as internally motivating.  Individual 
interpretation is the ultimate decision in how legal incentive is interpreted regardless of how 
it may seem to outside observers.  As such, it is important to recognize that the underlying 
motivation is not clear and is likely more complex and not unidemensional.   
Client legal status, including pressure to enter treatment, effects the length of 
treatment stay as clients with legal involvement are more likely to, stay in treatment for 
longer periods of time (Hubbard et al., 1989; Simpson, 1993), and successfully complete 
treatment (Hser et al., 2004; Maglione, Chao, & Anglin, 2000) than those without legal 
involvement. This was supported by the current study as legal status was found to 
significantly impact treatment retention.  Participants with legal incentives are almost twice 
as likely as those without legal incentive to still be in treatment at study completion.  
Retention within the current study was exceptionally high for an outpatient substance abuse 
programs.  It is this higher retention overall that may have resulted in not seeing a main effect 
for MET.  Given these higher rates of retention, it is possible that a ceiling effect may be 
leading to the mistaken conclusion that MET had no effect.  These higher rates of retention 
may be the results of many things, including, exceptional programs with well trained staff (in 
part due to the training and oversight of the CTN) or because of enhanced attention as a 
result of being a part of this study. 
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Treatment retention is one of the strongest predictors of abstinence at twelve month 
follow up (Simpson, Joe, Brown, 1997).  Treatment retention is also a potent and consistent 
predictor of positive treatment outcomes such as decreases in drug and alcohol use (Chou et 
al., 1998; Etheridge, Hubbard, Anderson, Craddock, & Flynn, 1997), decreases in criminal 
activity (Etheridge, Hubbard, Anderson, Craddock, & Flynn, 1997; Hser, Evans, Huang, and 
Anglin, 2004; Roffman, Klepsch, Wertz, Simpson, & Stephens, 1993) and improved social 
functioning (Hser, Evans, Huang, and Anglin, 2004; Roffman, Klepsch, Wertz, Simpson, & 
Stephens, 1993; Simpson & Joe, 2004; Simpson, Joe, and Rowan-Szal, 1997; Simpson & 
Sells, 1982).  The present study and much of the existing literature supports the fact that 
patients with legal incentives to enter treatment are retained in treatment longer than 
participants who are not legally incentivized.  Given that participants in this study with legal 
incentives to enter treatment are almost twice as likely to still be in treatment at 16 week post 
enrollment, it was not surprising that they also reported lower rates of primary substance use.  
It was somewhat surprising that the type of intervention (MET or TAU) made no difference.  
It is possible legal incentives, as they were measured in the current study, were so compelling 
that they overshadowed any potential treatment effects.  It is also worth noting that the 
overall retention rates of the current study were higher (69%) than is normally seen in an 
outpatient treatment program (25-40%) (Justus et al., 2006; Sayre et al., 2002; Siqueland et 
al., 2002; Wickizer et al., 1994) and this potentially made it more difficult to observe any 
treatment effects that may have been present.    
Motivation.  In psychology, motivation is often  defined as “the process that initiates, 
guides and maintains goal-oriented behaviors” (“Merriam-Webster's”, 2003).  In the field of 
addiction, it is considered by many to be integral to the recovery process.  A client’s level of 
90 
 
motivation at treatment onset has also been found to be positively associated with therapeutic 
participation and therapeutic alliance (Brocato, 2004; Brocato & Wagner, 2008; Joe et al., 
1999), which also appears to be related to increased retention and engagement (Brocato & 
Wagner, 2008; Simpson, Joe, Rowan Szal, & Greener, 1997).  In traditional 12-Step focused 
recovery programs, motivation is often viewed as a trait; something an individual possesses 
when he/she enters drug abuse treatment.  In contrast, the principles of motivational 
interviewing that form the basis for MET view motivation as a state that is subject to change 
and that therapists can help to guide individuals in the direction of change. 
In contrast to such internal motivation, legal issues that prompt (or even require) that 
a person seek drug abuse treatment, are seen as a marker for extrinsic motivation to seek 
care.  Some might argue such external pressure to enter treatment undermines internal self-
motivation (Brecht, Anglin, & Wang, 1993; Shearer & Ogan, 2002) such that persons with 
strong external pressure to enter treatment are, for all practical purposes, incapable of being 
self-motivated to change.  The present study explored this issue using a categorical measure 
that classified participants as having either high or low motivation to change based on 
URICA Readiness to Change scores.  
While the present study affirmed a relationship between legal incentives to enter 
treatment and low readiness to change, with nearly three-fourths of legally incentivized 
participants categorized as low readiness to change (71.4%), it was not absolute.  That is 
more than one fourth (28.6%)  of those entering treatment with legal pressure to do so 
nonetheless reported high motivation to change.  This is an interesting group that warrants 
further study.  In particular, it would be important to compare the congruent and incongruent 
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cases so that demographic and psychosocial correlates may be identified.  Such correlates 
may be useful in treatment planning and relapse prevention.  
 For the sake of simplicity, a mean separated readiness to change score was used 
(high readiness to change, low readiness to change) to establish participants baseline 
motivation.  The findings from the current study showed that the dichotomous Readiness to 
Change score had comparable cut off scores to the ATCC algorithm.  The ATCC algorithm 
(Callahan, Taylor, Moore, Jungerman, Vilela & Bundy, 2008) suggests that precontemplation 
range from -2 to 10.15.  The mean separation resulted in a low motivation (comparable to 
precontemplation) ranging from -2 to 10.16.  Using mean separation, a total of 225 
participants were categorized as low motivation, while 226 were categorized as high 
motivation.  The decision to mean separate the Readiness to Change score into high and low 
resulted in an almost identical split point, suggesting that using the mean separation scores 
was appropriate.   
Using the URICA readiness to change score as a measure of motivation, the current 
study looked at level of substance use and treatment retention.  The readiness to change score 
is based on the Transtheoretical Model of Change (discussed in greater detail in the literature 
review) and attempts to classify individuals through the stages of change; precontemplation, 
contemplation, preparation, action (Callahan, Taylor, Moore, Jungerman, Vilela & Bundy, 
2008).  Greater treatment gains were predicted for individuals in the MET condition who had 
low motivation scores but this was not the case. Instead, the readiness to change score was 
not predictive of treatment outcome as measured by substance use and retention. The existing 
body of research focused on the predictive validity of the URICA readiness to change score 
has found mixed results.  There is a growing body of research to suggest that the URICA is 
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not an adequate tool for use as a predictive measurement (Callahan, Taylor, Moore, 
Jungerman, Vilela & Bundy, 2008; Blanchard et al., 2003; Callaghan et al., 2007; 
Diclemente et al., 2004; Kinnaman, Bellack, Brown, & Yang, 2007; Pantalon, Nich, 
Frankforter, & Carroll, 2002; Pantalon & Swanson, 2003).  Additionally, several studies have 
shown that readiness to change scores were not related to changes in frequency or intensity 
of substance use and that baseline scores could not predict subsequent improvements in drug 
use outcomes (Callahan, Taylor, Moore, Jungerman, Vilela & Bundy, 2008; Blanchard et al., 
2003; Callaghan et al., 2007; Diclemente et al., 2004; Kinnaman, Bellack, Brown, & Yang, 
2007; Pantalon, Nich, Frankforter, & Carroll, 2002).  Findings from the current study show 
that baseline motivation does not result in different outcomes in substance use or treatment 
retention.   
Given the existing body of research in support of motivation at treatment outset being 
predictive of treatment participation it was surprising that no predictive effects were present 
in the current study.  This suggests the possibility that the URICA measure may assess 
readiness to change but not readiness for treatment.  Readiness for treatment is different from 
readiness to change in that it suggests an openness to treatment participation.  A large body 
of research has focused on readiness for treatment rather than readiness to change, and 
although these two constructs are likely related, they remain distinct (DiClemente et al., 
1999). For example, a client may want to change a specific behavior but may not be open to 
the idea of treatment assisting in that process. Although measurement of readiness to change 
from the URICA was not found to be predictive, it does not mean that motivation is not 
related to decreases in substance use and retention in treatment.  It may be that the measure 
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used in the current study (URICA Readiness to Change score) did not adequately assess the 
clients’ motivation for treatment.   
Study Strengths, Limitations, and Future Directions  
Strengths.  The current study has a number of strengths.  First, this was a large multi-
site study with a heterogeneous group of community treatment programs.  As part of the 
NIDA CTN, these were actual programs that typically did not participate in randomized 
clinical trials.  This is important, because previously conducted clinical trials have been 
limited by so many inclusion/exclusion criteria, that final study participants bore little 
resemblance to the substance abuse patients served by programs through the USA.  The 
present study kept exclusion criteria to a minimum, making every effort to maintain study 
representativeness and generalizability.   
Secondly, study assessments used standardized measures with well established 
reliability and validity.  Staff training in their administration was rigorous with ongoing 
monitoring for fidelity throughout the study.   For this study, in particular, data were 
abstracted from the Addiction Severity Index (ASI ‘lite’) and the Substance Use Calendar, 
both of which have been shown to be reliable and valid for measuring changes in substance 
use and other outcomes over time (McLellan, et al., 1992; Sobell & Sobell, 1992; Miller and 
Dleboca, 1994; Fals-Stewart et. al. 2000).  This ensured that information was gathered 
accurately and consistently with minimal experimenter error across participating study sites.   
Third, both MET and TAU were delivered by actual therapists from the participating 
treatment programs.  None had prior allegiance to, or experience with, MET.  Therapist 
training was rigorous with certification and careful fidelity monitoring of both the 
experimental (MET) and control (TAU) interventions. 
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Fourth, a randomized clinical trial was used to compare MET and TAU in the context 
of ongoing outpatient substance abuse treatment.  Urn randomization was used to minimize 
chance differences in demographic and other variables between study groups. 
Finally, the data set had been carefully monitored throughout study administration.  
At study completion, quality assurance procedures were in place to review files for data 
accuracy. In addition, prior to testing current study hypotheses, a rigorous set of procedures 
were undertaken to replicate not only the descriptive tables for the primary outcome paper, 
but also the main study results.  Ultimately, this effort brought to light the difference in the 
pattern of findings over the course of the 16 week study period.  That is, one of the primary 
outcome variables (days of substance use), when examined concurrently for the 4 study 
groups (legal incentive/MET; legal incentive/TAU; no legal incentive/MET; no legal 
incentive/TAU) showed a different pattern during the initial phase (weeks 1-4) as compared 
to what was seen in the subsequent phase (weeks 5-16).  In fact, not only was the pattern of 
use dissimilar for the two phases, but in some cases the trend was an opposite direction.  
When data were analyzed as originally proposed, hypothesis testing yielded negative results.  
However, in the exploratory analyses that arose following replication of the primary paper 
results, significant interactions were found between MET and the presence or absence of 
legal incentives to enter treatment. 
Clearly, further research is needed to better understand the interactions that were 
found and the different patterns of substance use found across the 4 groups of participants in 
the 2 phases of the study.  Since the first phase could be considered treatment engagement 
(weeks 1-4) and the second phase might be considered early treatment retention (weeks 5-
16), this is worthy of study as these are the two targets of MET.  Since this was the first time 
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research had been blended with ongoing clinical practice at these sites, the varied patterns 
could in part be the result of increased time and attention contributed by the presence of RAs 
and more frequent monitoring and assessment.       
Limitations.  It is important to also recognize the limitations of this study.  First, as a 
secondary data analytic study, testing of the hypotheses for the present study was done within 
the confines of available measures and how information was entered into the computer 
database for analysis.  In some cases, creation of new variables presented problems or 
required modifications to proposed analyses.  Related to this, a second limitation was the 
focus on primary substance used.  While this categorization was supported in the literature 
(Ball et al., 2007; Carroll et al. 2006) it does not tell the full story.  Types of substances used 
can change for a number of reasons (e.g. being drug tested and fearing consequences, 
availability) and by focusing on only the primary substance used at study enrollment we 
potentially missed changes in substance used.   A third limitation was sample size.  Clearly 
an N of 461 was sufficient for the primary clinical trial comparing MET to TAU, as well as 
subsequent comparisons of participants with primary alcohol versus other drug(s).  The 
present study, however, proposed further sub grouping and further reductions in cell counts 
created limitations in variables that could be created to capture legal incentives to enter 
treatment and baseline levels of motivation to change.    Related to this, the fourth limitation 
was the use of a dichotomous variable to represent legal incentive to enter treatment.  
Clearly, a more refined measure was preferred, and a  3-category variable was considered 
(mandated to treatment, other legal involvement, no legal involvement,  reductions in 
subgroup sample sizes made  this less feasible.  Nonetheless, while using a trinomial variable 
seemed to have merit, there was nonetheless also support in the literature for the 
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dichotomous measure used in this study (Niv, Hamilton, Hser, 2009; Craddock, Rounds-
Bryant, Flynn, & Hubbard, 1997).   
A fifth limitation is the better than expected overall outcomes for all study 
participants.  For example, while between 60-75% of outpatients in substance abuse 
treatment tend to drop out during the first few months of care (Justus et al., 2006; Sayre et al., 
2002; Siqueland et al., 2002; Wickizer et al., 1994), only one-third (31%) did so in the 
current study sample.  This may have created a ceiling effect for the outcome variable of 
treatment retention, measured at 16 weeks post-study enrollment.  It is unclear why the 
current study had higher rates of participant retention than traditional outpatient programs 
report.  It is possible that in this study the retention was higher because of the additional 
focus and attention provided because of the research study (e.g. study visits, contact with the 
RA).   
Future Directions.  While much of the research has focused on client characteristics, 
future directions should also focus on programmatic factors.  Multi-site trials, such as this, 
lend themselves to just such an assessment of programmatic factors.   Clearly not all 
programs and not all treatments are created equally.  A focus on programmatic factors 
associated with improved retention and decreases in primary substance use for legally 
involved clients could be an important step towards gaining a better understanding of the 
predictors of treatment retention, while also helping to provide a more complete picture of 
the occurrence of substance treatment drop-out among this population. 
More than one fourth  of those entering treatment with legal pressure did so while 
reporting high motivation to change.  This is an interesting group that warrants further study.  
Measures, such as the URICA, are useful but they may not tell the whole story.  While 
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qualitative approaches are seldom employed within substance abuse treatment research they 
may provide a better way to understand the characteristics of this group. Employing a 
qualitative component to a quantitative investigation could prove quite useful in determining 
factors related to retention.  
From the current study it appears that the role of legal incentives didn’t strengthen 
MET.  Theory suggests that a motivationally enhancing program, with exceptional training 
and fidelity monitoring as seen in the CTN, should result in differences in substance use and 
retention.    Further research is needed to assess what, if any, role that MET can have with 
this population.  Findings from the exploratory analysis present one future area where this 
could be assessed.  Results from the exploratory analyses show a different response to MET 
at different time points (intervention, post-intervention) among those with and without legal 
incentives.  This transition point is worth further exploration. 
Consistent with many previous studies, the present study affirmed an association 
between legal incentives to enter care and treatment outcomes of substance use and treatment 
retention.   That is, participants who were legally encouraged to enter treatment displayed a 
more rapid and steeper reduction than those without legal encouragement.  Legally 
encouraged participants also had retention rates two times higher than those without legal 
involvement.  What remains unclear, however, is what happened to substance use for these 
individuals after the legal incentives are no longer present.  It is possible that treatment 
effects may not hold if an individual is motivated to complete treatment to satisfy a court 
order rather than an internal desire to alter the substance use?  Research in support of this 
comes from Brecht, Anglin & Whang (1993) who showed that client relapse rates can 
increase significantly once monitoring probation programs end.  While relapse may occur 
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after the removal of legal incentives, this is not necessarily a negative outcome in all cases.  
For example, from a harm reduction standpoint, reductions in substance use and engagement 
in treatment during the time a person has active legal issues should not be ignored.  
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